Tag: adrenoaceptor

44 PALLETS 3062 CARTONS PH ARMACEUTICALS AS UNDER TELM ISARTAN TAB 80MG 30 NDC CODE: 68462020130 HTS NO : 3004.90. 92.20 FDA CODE : 62 O C A 09 ANDA NO.: 90032 THERAPEUTICE USE : INDICATED FOR THE TRE MNBU4342643 001 ATMENT OF HYPERTENSION, TO LO WER BLOOD PRESSURE ATOMOXE TINE CAP 100MG 30 NDC CODE:68 462027130 FDA PRODUCT CODE NO .: 64 UCA 99 H. T. S NO.: 3 004.90.92.90 ANDA NO.: 079019 TREATMENT OF ATTENTION - DE FICIT/HYPERACIVITY DISORDER ( MNBU4342643 001 ADHD NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PR ODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 A NDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANAL GESIC FELODIPINE ER TAB 2.5 MG 100 NDC CODE:68462023301 MNBU4342643 001 FDA PRODUCT CODE NO.: 62OCB32 H. T. S NO.: 3004.90.92.20 ANDA NO.: 90-365 THERAPEUTIC E USE: - TREATMENT OF HYPERT ENSION GABAPENTIN TAB 800MG 500 NDC CODE:68462012705 FD A PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA MNBU4342643 001 NO.:-77-662 THERAPEUTICE USE :-ANTICONVULSANT OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N O.:62KCF10 HTS NO.3004.90.925 5 ANDA NO.:91672 THERAPEUTIC E USE: -TREATMENT OF TREAT G ASTROESOPHAGEAL REFLUX DISEAS MNBU4342643 001 E ROSUVASTATIN TAB 20MG 90 NDC CODE:68462026390 FDA PRO DUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 AND A NO.: 079172 THERAPEUTICE US E: - TO TREAT HIGH CHOLESTERO L AND RELATED CONDITIONS, AN D TO PREVENT CARDIOVASCULAR D MNBU4342643 001 ISEASE CARVEDILOL TAB 6.25M G 500 NDC CODE:68462016305 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST AC RLF ADAPALENE GEL 0.1 % 45GM (CURIST) NDC CODE:7255 MNBU4342643 001 9001513 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 208108 THERAPEUTICE USE: #TOPICAL ANTI-ACNE AGENT COMMERCIAL & CUSTOM INVOICE NO. F2245200 6396 DT. 27.03.2024 F22452006 395 DT. 27.03.2024 F224520063 MNBU4342643 001 86 DT. 27.03.2024 F2245200641 3 DT. 28.03.2024 F22452006410 DT. 28.03.2024 F22452006412 DT. 28.03.2024 F22452006401 D T. 28.03.2024 S/BILL NO: 8717 970 DT 28-MAR-2024 S/BILL NO: 8718032 DT 28-MAR-2024 S/BIL L NO: 8717979 DT 28-MAR-2024 MNBU4342643 001 S/BILL NO: 8718030 DT 28-MAR-2 024 S/BILL NO: 8718031 DT 28- MAR-2024 S/BILL NO: 8717940 D T 28-MAR-2024 S/BILL NO: 8717 939 DT 28-MAR-2024 NET WT. 94 10.872 KGS 09 DATA LOGGERS SET TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK P MNBU4342643 001 HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA H - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWI TZERLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERL AND NOTIFY PARTY:4 CURIST C/ O BAKER INDUSTRIES 184 PENNSY MNBU4342643 001 LVANIA AVE PENNSYLVANIA MALV ERN USA- 19355 LABELER CODE : 68462:

42 PALLETS 2227 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CO DE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT MNBU3754230 001 IS AN ANTI-ANGINAL MEDICATIO N. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) A TTACK OF ANGINA EZETIMIBE- MNBU3754230 001 SIMVA TAB 10/80MG 30 NDC CODE :68462032430 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO .: 3004.49.00.10 ANDA NO.: 2 08699 THERAPEUTICE USE: - THI S COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLES TEROL AND FATS (SUCH AS LDL, MNBU3754230 001 TRIGLYCERIDES) AND RAISE GOO D CHOLESTEROL (HDL) IN THE BL OOD. EZETIMIBE WORKS BY REDUC ING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "S TATINS." IT WORKS BY REDUCING MNBU3754230 001 THE AMOUNT OF CHOLESTEROL M ADE BY THE LIVER. CARVEDILO L TAB 25MG 500 NDC CODE:68462 016505 FDA PRODUCT CODE NO : 62 O C A 22 HTS NO.3004.90.92 21 ANDA NO.78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST RANOLAZINE ER T MNBU3754230 001 AB 500MG 60 NDC CODE:68462031 960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004. 49.00.10 ANDA NO.:211082 THE RAPEUTIC USE: - IT IS AN ANTI -ANGINAL MEDICATION. IT WORKS BY IMPROVING BLOOD FLOW TO HELP THE HEART WORK MORE EFFI MNBU3754230 001 CIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURING AN A CUTE (EMERGENCY) ATTACK OF A NGINA CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA NO. MNBU3754230 001 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 25MG 100 ND C CODE:68462016501 FDA PRODUC T CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST TER MNBU3754230 001 IFLUNOMIDE TAB 7MG 30 NDC COD E:68462042330 FDA PRODUCT COD E NO.: 60 L C A 99 H. T. S NO.:3004.90.9215 ANDA NO.: 20 9663 THERAPEUTICE USE: :#MUL TIPLE SCLEROSIS AGENT TACR OLIMUS OINT 0.1% 100GM NDC CO DE:68462053494 FDA PRODUCT CO MNBU3754230 001 DE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICAL IMMUN OSUPPRESSIVE OINTMENT USED FO R THE TREATMENT OF MODERATE- TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SIROLIMUS TAB 1MG MNBU3754230 001 100 NDC CODE:68462068301 FD A PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90.92.1 5 ANDA NO.: 208691 THERAPEUT ICE USE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. AP REPITANT CAP 40MG 1UD NDC COD E:68462058340 FDA PRODUCT COD MNBU3754230 001 E NO.: 61 T C E 32 H. T. S N O.: 3004.90.92.40 ANDA NO.: 207777 THERAPEUTICE USE: -AP REPITANT IS USED WITH OTHER M EDICATIONS TO HELP PREVENT NA USEA AND VOMITING CAUSED BY CANCER DRUG TREATMENT (CHEMOT HERAPY). THIS MEDICATION IS A MNBU3754230 001 LSO USED TO PREVENT NAUSEA AN D VOMITING AFTER SURGERY. A- EMETIC/NAUSEANT / HUMAN - RX/ SINGLE INGREDIENT / DELAYED RELEASE TABLETS / APREPITANT COMMERCIAL & CUSTOM INVOICE NO. F22487002342 DT. 20.03.2 024 F22487002345 DT. 21.03.20 MNBU3754230 001 24 F22487002346 DT. 21.03.202 4 F22487002347 DT. 21.03.2024 F22487002348 DT. 21.03.2024 S/BILL NO: 4004831 DT: 21/03/ 2024 S/BILL NO: 4004832 DT: 2 1/03/2024 S/BILL NO: 4004833 DT: 21/03/2024 S/BILL NO: 400 4834 DT: 21/03/2024 S/BILL NO MNBU3754230 001 : 4004835 DT: 21/03/2024 GROS S WT. 10,515.652 NET WT.7695 .876 13 DATA LOGGERS SE T TEMPERATURE : +20 DEGREES NOTIFY PARTY:2 GLENMARK PHAR MACEUTICALS INC 750, CORPORAT E DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 G MNBU3754230 001 LENMARK SPECIALTY S.A. SWITZE RLAND (GSSA) PLACE DU PORT 2 NEUCHATEL - 2000 SWITZERLAND

CARVEDILOL TAB 12.5MG 500 3220 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 12.5MG 500 NDC CODE 68462016405 FDA PRODUCT CODE NO 62 O C A 22 HLBU9326116 001 HTS NO.3004.90.9221 ANDA NO.78-251 THERAPEUTICE USE -BETA- ADRENOACEPTOR ANTAGONIST BISOPROLOL-HCTZ TAB 5/6.25MG 100 HLBU9326116 001 NDC CODE 68462087901 FDA PRODUCT CODE NO 62 O D A 18 HTS NO.3004.49.0010 ANDA NO.215995 THERAPEUTICE USE -BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZIDE HLBU9326116 001 TABLETS ARE INDICATED IN THE MANAGEMENT OF HYPERTENSION. EZETIMIBE-SIMVA TAB 10/10MG 30 NDC CODE 68462032130 FDA PRODUCT CODE NO. HLBU9326116 001 61 J D C 15 H. T. S NO. 3004.49.00.10 ANDA NO. 208699 THERAPEUTICE USE - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTEROL AND HLBU9326116 001 FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN HLBU9326116 001 BELONGS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. INDOMETHACIN ER CAP 75MG 60 NDC CODE 68462032560 FDA PRODUCT CODE 62 HLBU9326116 001 GCE42 H. T. S NO. 3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ARTHRITIS, GOUT, BURSITIS, HLBU9326116 001 AND TENDONITIS. IT IS ALSO USED TO RELIEVE PAIN FROM VARIOUS OTHER CONDITIONS. THIS MEDICATION IS KNOWN AS A NONSTEROIDAL ANTI-INFLAMMATORY DRUG (NSAID). ... HLBU9326116 001 THIS EFFECT HELPS TO DECREASE SWELLING AND PAIN. TACROLIMUS OINT 0.1% 30GM NDC CODE 68462053435 FDA PRODUCT CODE NO. 64 T C J 08 H. T. S NO. HLBU9326116 001 3004.49.00.50 ANDA NO. 210393 THERAPEUTICE USE - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE HLBU9326116 001 ATOPIC DERMATITIS (ECZEMA). TACROLIMUS CAP 1MG 100 NDC CODE 68462068601 HTS NO 3004.90.92.15 FDA CODE 64 T C E 08 ANDA NO.206662 THERAPEUTIC USE TO HLBU9326116 001 PREVENT REJECTION OF A KIDNEY,HEART, OR LIVER TRANSPLANT XX CARGO DESCRIPTION XX

45 PALLETS 4024 CARTONS PH ARMACEUTICALS AS UNDER ONDA NSETRON ODT 8MG 30UD NDC CODE :68462015813 FDA PRODUCT CODE .:-61 T C A 26 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-1 52 THERAPEUTICE USE:-ANTI -E MNBU0637055 001 METIC GABAPENTIN TAB 600MG 500 NDC CODE:68462012605 FDA PRODUCT CODE:NO : 61 N C A 6 9 HTS NO.3004.90.9236 ANDA N O.:-77-662 THERAPEUTICE USE: -ANTICONVULSANT CARVEDILOL TAB 6.25MG 500 NDC CODE:68462 016305 FDA PRODUCT CODE NO : MNBU0637055 001 62 O C A 22 HTS NO.3004.90.92 21 ANDA NO.78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR ANTAGONIST GABAPENTIN TAB 600MG 500 NDC CODE:6846201260 5 FDA PRODUCT CODE:NO : 61 N C A 69 HTS NO.3004.90.9236 ANDA NO.:-77-662 THERAPEUTICE MNBU0637055 001 USE:-ANTICONVULSANT ROSUV ASTATIN TAB 5MG 90 NDC CODE:6 8462026190 FDA PRODUCT CODE NO.:61 J C A 16 H. T. S NO.: 3004.49.00.10 ANDA NO.: 0791 72 THERAPEUTICE USE: - TO TR EAT HIGH CHOLESTEROL AND RELA TED CONDITIONS, AND TO PREVEN MNBU0637055 001 T CARDIOVASCULAR DISEASE C OMMERCIAL & CUSTOM INVOICE NO. F22452005269 DT. 30.01.2024 F22452005270 DT. 30.01.2024 F22452005271 DT. 30.01.2024 F 22452005291 DT. 31.01.2024 F2 2452005272 DT. 30.01.2024 S/B ILL NO: 7169775 DT 31-JAN-2024 MNBU0637055 001 S/BILL NO: 7169737 DT 31-JAN -2024 S/BILL NO: 7169716 DT 3 1-JAN-2024 S/BILL NO: 7169778 DT 31-JAN-2024 S/BILL NO: 71 71010 DT 31-JAN-2024 NET WT. 9,025.77 KGS 11 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +20 DEGREES TEMPERATURE MNBU0637055 001 RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA NOTIFY PARTY :3 GLENMARK SPECIALTY S.A. S WITZERLAND (GSSA) PLACE DU PO RT 2 NEUCHATEL - 2000 SWITZE MNBU0637055 001 RLAND

40 PALLETS 2197 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 25MG 500 NDC CODE: 68462016505 FDA PRODUCT CODE NO :62 O C A 22 HTS NO.3004. 90.9221 ANDA NO.78-251 THERA PEUTICE USE:-BETA- ADRENOACE MNBU0602763 001 PTOR ANTAGONIST NICARDIPIN E HCL CAP 30MG 90 NDC CODE:68 462012190 FDA PRODUCT CODE NO .: 62 O C E 48 H. T. S NO.: 3004.90.9220 ANDA NO.: 21635 7 THERAPEUTICE USE: :#CARDIO VASCULAR AGENT (CALCIUM CHANN EL BLOCKER) EZETIMIBE-SIMV MNBU0602763 001 A TAB 10/20MG 30 NDC CODE:684 62032230 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: :#LIPID LOWERING AGENT GABAPENTIN T AB 600MG 500 NDC CODE:6846201 2605 FDA PRODUCT CODE:NO : 6 MNBU0602763 001 1 N C A 69 HTS NO.3004.90.923 6 ANDA NO.:-77-662 THERAPEUT ICE USE:-ANTICONVULSANT PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0602763 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS EZETIMIBE-S IMVA TAB 10/20MG 90 NDC CODE: 68462032290 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 MNBU0602763 001 8699 THERAPEUTICE USE: :#LIP ID LOWERING AGENT RUFINAMID E TAB 400MG 120 NDC CODE:6846 2071408 61 M C A 99 3004.90. 92.30 205075 TO USED WITH OT HER MEDICATIONS TO PREVENT OR CONTROL SEIZURES (EPILEPSY) ASSOCIATED WITH LENNOX-GAST MNBU0602763 001 AUT SYNDROME (LGS BISOPROL OL-HCTZ TAB 10/6.25MG 30 NDC CODE:68462088030 FDA PRODUCT CODE NO :62 O D A 18 HTS NO. 3004.49.0010 ANDA NO.215995 THERAPEUTICE USE:-BISOPROLOL FUMARATE AND HYDROCHLOROTHIAZ IDE TABLETS ARE INDICATED IN MNBU0602763 001 THE MANAGEMENT OF HYPERTENS ION. FENOFIBRATE CAP 67MG 1 00 NDC CODE:68462058001 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004.90.92.20 A NDA NO.: 205566 THERAPEUTICE USE: - INDICATED AS ADJUNCTIV E THERAPY TO DIET FOR THE RE MNBU0602763 001 DUCTION OF LDL-C, TOTAL-C, TR IGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPER CHOLESTEROLEMIA OR MIXED DYSL IPIDEMIA CARVEDILOL TAB 25M G 500 NDC CODE:68462016505 F DA PRODUCT CODE NO :62 O C A 22 HTS NO.3004.90.9221 ANDA MNBU0602763 001 NO.78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST TACROLIMUS OINT 0.1% 100 GM NDC CODE:68462053494 FDA PRODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210393 THERAPEUTIC E USE: - TACROLIMUS IS A TOPI MNBU0602763 001 CAL IMMUNOSUPPRESSIVE OINTME NT USED FOR THE TREATMENT OF MODERATE-TO-SEVERE ATOPIC DE RMATITIS (ECZEMA). TACROLI MUS OINT 0.1% 30GM NDC CODE:6 8462053435 FDA PRODUCT CODE N O.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 210 MNBU0602763 001 393 THERAPEUTICE USE: - TACR OLIMUS IS A TOPICAL IMMUNOSUP PRESSIVE OINTMENT USED FOR TH E TREATMENT OF MODERATE-TO-S EVERE ATOPIC DERMATITIS (ECZ EMA). PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 F DA PRODUCT CODE NO.: 61 S C J MNBU0602763 001 04 H. T. S NO.: 3004.90.92. 45 ANDA NO.: 211769 THERAPEU TICE USE: - AS SECOUND-LINE T HERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERT MENT OF MILD TO MODERATE ATOP IC DERMATITIS IN NONIMMUNOCO MPROMISED ADULT AND CHILDREN MNBU0602763 001 2 YEARS OF AGE TACROLIMUS OINTMENT 0.03% 100GM NDC CODE :68462088194 FDA PRODUCT CODE NO.:64 T C J 08 H. T. S NO. : 3004.49.0050 ANDA NO.:2103 93 THERAPEUTICE USE: TOPICAL IMMUNOSUPPRESSIVE AGENT COMMERCIAL & CUSTOM INVOICE NO MNBU0602763 001 . F22487001926 DT. 22.01.2024 F22487001922 DT. 20.01.2024 F22487001921 DT. 20.01.2024 F22487001920 DT. 20.01.2024 F 22487001919 DT. 20.01.2024 F2 2487001917 DT. 20.01.2024 S/B ILL NO: 4001056 DT: 22/01/2024 S/BILL NO: 4001055 DT: 22/01 MNBU0602763 001 /2024 S/BILL NO: 4001053 DT: 22/01/2024 S/BILL NO: 4001054 DT: 22/01/2024 S/BILL NO: 40 01052 DT: 22/01/2024 S/BILL N O: 4001051 DT: 22/01/2024 NET WT. 5823.454 KGS 02 DATA LO GGERS HUMIDITY:65% SET TEMPE RATURE : +20 DEGREES TEMPERAT MNBU0602763 001 URE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH-07430 USA

NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAP EUTICE USE:-ANTI-INFLAMMATORY, ANALGESIC CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016 305 FDA PRODUCT CODE NO :62 O C A 22 HTS N O.3004.90.9221 ANDA NO.78-251 THERAPEUTICE HLBU9755872 001 USE:-BETA- ADRENOACEPTOR ANTAGONIST NAP ROXEN TAB 500MG 500 NDC CODE:68462019005 FD A PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78-250 THERAPEUT ICE USE:-ANTI-INFLAMMATORY, ANALGESIC NA PROXEN TAB 500MG 500 NDC CODE:68462019005 F DA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-78-250 THERAPEU HLBU9755872 001 TICE USE:-ANTI-INFLAMMATORY, ANALGESIC O NDANSETRON ODT 8MG 30UD NDC CODE:68462015813 FDA PRODUCT CODE.:-61 T C A 26 H. T. S NO .: 3004.90.92.40 ANDA NO.:-78-152 THERAPEU TICE USE:-ANTI -EMETIC ZONISAMIDE CAP 100 MG 500 NDC CODE:68462013005 FDA PRODUCT COD E NO.:-61 M C E 44 H. T. S NO.: 3004.49.00 .20 ANDA NO.:-77-651 THERAPEUTICE USE:-ANT HLBU9755872 001 ISEIZURE DRUG OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68462039710 FDA PRODUCT CODE NO.: 62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 20MG 1000 NDC CODE:68462039610 FDA PRO DUCT CODE NO.:62KCF10 HTS NO.3004.90.9255 ANDA NO.:91672 THERAPEUTICE USE: -TREATMENT HLBU9755872 001 OF TREAT GASTROESOPHAGEAL REFLUX DISEASE ROPINIROLE TAB 0.25MG 100 NDC CODE:6846202 5301 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TREATMENT OF PARKINSONISM NAPROXEN TAB 500MG 500 NDC CODE:68462019 005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 TH HLBU9755872 001 ERAPEUTICE USE:-ANTI-INFLAMMATORY, ANALGESI C CARVEDILOL TAB 6.25MG 500 NDC CODE:6846 2016305 FDA PRODUCT CODE NO :62 O C A 22 H TS NO.3004.90.9221 ANDA NO.78-251 THERAPEUT ICE USE:-BETA- ADRENOACEPTOR ANTAGONIST 03 DATA LOGGERS HUMIDITY:65% SET TEMPER ATURE : +20 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES CONTAINER NO. HLBU97 HLBU9755872 001 55872 COMMERCIAL & CUSTOM INVOICE NO. F2245 2005336 DT. 31.01.2024 F22452005362 DT. 31.0 1.2024 F22452005376 DT. 31.01.2024 F2245200 5351 DT. 31.01.2024 F22452005359 DT. 31.01.2 024 F22452005379 DT. 31.01.2024 F2245200531 2 DT. 31.01.2024

51 PALLETS 4714 CARTONS PH ARMACEUTICALS AS UNDER PRAM IPEXOLE TAB 0.125MG 90 NDC CO DE:68462033090 FDA PRODUCT CO DE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USE MNBU0427378 001 D IN PARKINSON#S DISEASE R OPINIROLE TAB 2MG 100 NDC COD E:68462025601 FDA PRODUCT COD E NO.:-62 J C A 17 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 90-135 THERAPEUTICE USE:-TR EATMENT OF PARKINSONISM ON DANSETRON TAB 4MG 30 NDC CODE MNBU0427378 001 :68462010530 FDA PRODUCT CODE NO.:-61 T C A 28 H. T. S NO .: 3004.90.92.40 ANDA NO.:- 77-535 THERAPEUTICE USE:-ANTI -EMETIC CARVEDILOL TAB 25 MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92 MNBU0427378 001 .20 ANDA NO.:- 78-251 THERAP EUTICE USE:-BETA- ADRENOACEP TOR ANTAGONIST TELMISARTAN TAB 40MG 30 NDC CODE:6846202 0030 FDA PRODUCT CODE NO.: 6 2 O C A 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.:090032 TH ERAPEUTICE USE: INDICATED FOR MNBU0427378 001 THE TREATMENT OF HYPERTENSI ON, TO LOWER BLOOD PRESSURE ZONISAMIDE CAP 100MG 100 ND C CODE:68462013001 FDA PRODUC T CODE NO.:-61 M C E 44 H. T . S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE USE :-ANTISEIZURE DRUG ROPINIRO MNBU0427378 001 LE TAB 0.5MG 100 NDC CODE:684 62025401 FDA PRODUCT CODE NO .:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90-1 35 THERAPEUTICE USE:-TREATME NT OF PARKINSONISM CARVEDI LOL TAB 6.25MG 500 NDC CODE:6 8462016305 FDA PRODUCT CODE N MNBU0427378 001 O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST PRAVASTATIN SOD TAB 40MG 500 NDC CODE:68462019705 FDA PRO DUCT CODE NO.: 61 J C A 13 H . T. S NO.: 3004.90.92.20 AN MNBU0427378 001 DA NO.: 77-987 THERAPEUTICE U SE: -HYPOLIPDAEMIC PRAVAST ATIN SOD TAB 40MG 90 NDC CODE :68462019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO .: 3004.90.92.20 ANDA NO.: 7 7-987 THERAPEUTICE USE: -HYP OLIPDAEMIC GABAPENTIN TAB 6 MNBU0427378 001 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT OXCARBAZEPINE TAB 600M G 100 NDC CODE:68462013901 F DA PRODUCT CODE NO.:-61 M C A MNBU0427378 001 45 H. T. S NO.: 3004.90.92. 30 ANDA NO.:-77-802 THERAPEU TICE USE:-ANTI CONVULSANT AGE NT COMMERCIAL & CUSTOM INVO ICE NO. F22452004648 DT. 28.1 2.2023 F22452004649 DT. 28.12 .2023 F22452004696 DT. 29.12. 2023 F22452004697 DT. 29.12.2 MNBU0427378 001 023 F22452004735 DT. 30.12.20 23 F22452004752 DT. 30.12.202 3 S/BILL NO: 6460329 DT 01-JA N-2024 S/BILL NO:6460324 DT 0 1-JAN-2024 S/BILL NO: 6460328 DT 01-JAN-2024 S/BILL NO: 64 60323 DT 01-JAN-2024 S/BILL N O:6460326 DT 01-JAN-2024 S/BI MNBU0427378 001 LL NO: 6460325 DT 01-JAN-2024 NET WT. 9997.284 KGS 02 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JE MNBU0427378 001 RSEY MAHWAH - 07430 USA

45 PALLETS 3768 CARTONS PH ARMACEUTICALS AS UNDER ZONI SAMIDE CAP 100MG 100 NDC CODE :68462013001 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO .: 3004.49.00.20 ANDA NO.:-7 7-651 THERAPEUTICE USE:-ANTI MNBU0460695 001 SEIZURE DRUG ROPINIROLE TAB 0.5MG 100 NDC CODE:684620254 01 FDA PRODUCT CODE NO.:-62 J C A 17 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:- 90-135 TH ERAPEUTICE USE:-TREATMENT OF PARKINSONISM ZONISAMIDE CA P 100MG 500 NDC CODE:68462013 MNBU0460695 001 005 FDA PRODUCT CODE NO.:-61 M C E 44 H. T. S NO.: 3004. 49.00.20 ANDA NO.:-77-651 TH ERAPEUTICE USE:-ANTISEIZURE D RUG ONDANSETRON TAB 8MG 30 NDC CODE:68462010630 FDA PRO DUCT CODE NO.:-61 T C A 28 H. T. S NO.: 3004.90.92.40 AND MNBU0460695 001 A NO.:- 77-535 THERAPEUTICE U SE:-ANTI -EMETIC CARVEDILO L TAB 6.25MG 500 NDC CODE:684 62016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-2 51 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST C MNBU0460695 001 ARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRO MNBU0460695 001 DUCT CODE NO.:-62 G C A 49 H . T. S NO.: 3004.90.92.40 AN DA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFLAMMATORY, ANALG ESIC TOPIRAMATE TAB 100MG 5 00 NDC CODE:68462010905 FDA PRODUCT CODE NO.: 61 M C A 40 H. T. S NO.: 3004.49.00.20 MNBU0460695 001 ANDA NO.: 77627 THERAPEUTICE USE: :#ANTICONVULSANT OND ANSETRON ODT 8MG 10UD NDC COD E:68462015811 FDA PRODUCT COD E NO.:-61 T C A 26 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 78-152 THERAPEUTICE USE:-ANTI -EMETIC IMIQUIMOD CREAM 5 MNBU0460695 001 % 0.25GM 24 NDC CODE:68462053 670 FDA PRODUCT CODE NO.: 62 V C J 29 H. T. S NO.: 3004. 49.00.50 ANDA NO.:201994 THE RAPEUTICE USE: - INDICATED FO R ACTINIC KERATOSES AND EXTER NAL GENITAL AND PERIANAL WAR TS CICLOPIROX GEL 0.77% 30G MNBU0460695 001 M NDC CODE:68462045535 FDA P RODUCT CODE NO.: 61WCJ43 H. T. S NO.: 3004.49.00.50 ANDA NO.: 091595 THERAPEUTICE USE : - ANTIFUNGAL CICLOPIROX GEL 0.77% 45GM NDC CODE:68462 045547 FDA PRODUCT CODE NO.: 61WCJ43 H. T. S NO.: 3004.4 MNBU0460695 001 9.00.50 ANDA NO.: 091595 THE RAPEUTICE USE: - ANTIFUNGAL COMMERCIAL & CUSTOM INVOICE NO. F22452004746 DT. 30.12.20 23 F22452004750 DT. 30.12.202 3 F22452004737 DT. 30.12.2023 F22452004733 DT. 30.12.2023 F22452004744 DT. 30.12.2023 MNBU0460695 001 F22452004748 DT. 30.12.2023 F 22452004768 DT. 31.12.2023 F2 2452004680 DT. 29.12.2023 F22 452004809 DT. 31.12.2023 F224 52004804 DT. 31.12.2023 S/BIL L NO: 6479849 DT 02-JAN-2024 S/BILL NO: 6479850 DT 02-JAN-2 024 S/BILL NO: 6479845 DT 02- MNBU0460695 001 JAN-2024 S/BILL NO: 6479848 D T 02-JAN-2024 S/BILL NO: 6479 844 DT 02-JAN-2024 S/BILL NO: 6480417 DT 02-JAN-2024 S/BIL L NO: 6481033 DT 02-JAN-2024 S/BILL NO: 6480041 DT 02-JAN-2 024 S/BILL NO: 6479856 DT 02- JAN-2024 S/BILL NO: 6479847 D MNBU0460695 001 T 02-JAN-2024 NET WT. 7823.2 60 KGS 02 DATA LOGGERS HUMI DITY:65% SET TEMPERATURE : +2 0 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES N OTIFY PARTY:2 GLENMARK PHARMA CEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0 MNBU0460695 001 7430 USA

28 PALLETS 1662 CARTONS PH ARMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 20MG 90 NDC C ODE:68462019690 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H MNBU0526257 001 YPOLIPDAEMIC POTASSIUM CL E R CAP 10MEQ 100 NDC CODE:6846 2035701 FDA PRODUCT CODE NO. :65 R C F 14 H. T. S NO.: 30 04.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTION OF HYPOKALEMI A CARVEDILOL TAB 25MG 500 MNBU0526257 001 NDC CODE:68462016505 FDA PROD UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620357 01 FDA PRODUCT CODE NO.:65 R MNBU0526257 001 C F 14 H. T. S NO.: 3004.90 .92.90 ANDA NO.:202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOICE NO . F22487001671 DT. 19.12.2023 F22487001676 DT. 20.12.2023 S/BILL NO: 4019570 DT: 20/12/ MNBU0526257 001 2023 S/BILL NO: 4019567 DT: 2 0/12/2023 NET WT. 4808.164 K GS 02 DATA LOGGERS SET T EMPERATURE : +20 DEGREES NO TIFY PARTY:2 GLENMARK PHARMAC EUTICALS INC 750, CORPORATE D RIVE, NEW JERSEY MAHWAH - 07 430 USA

40 PALLETS 2798 CARTONS PH ARMACEUTICALS AS UNDER OMEP RAZOLE DR CAP 40MG 1000 NDC C ODE:68462039710 FDA PRODUCT C ODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.:91672 THERAPEUTICE USE: - TREATME MNBU0151926 001 NT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE TROSPIUM CL TAB 20MG 60 NDC CODE:6846204 6160 FDA PRODUCT CODE NO.:-6 1 K C A 69 H. T. S NO.: 3004 .49.00.70 ANDA NO.:-91-575 T HERAPEUTICE USE:- TREATMENT O F VENOUS DISEASES URINARY IN MNBU0151926 001 CONTINENCE THERAPY CARVEDI LOL TAB 3.125MG 500 NDC CODE: 68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 1000 MNBU0151926 001 NDC CODE:68462039710 FDA PRO DUCT CODE NO.:62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO. :91672 THERAPEUTICE USE: - T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE OLMES ARTAN MEDOX TAB 40MG 30 NDC C ODE:68462043830 FDA PRODUCT C MNBU0151926 001 ODE NO.: 62CCA68 H. T. S NO. : 3004.90.9220 ANDA NO.: 203 281 THERAPEUTICE USE: - -TRE ATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENS IVE AGENTS, TO LOWER BLOOD PR ESSURE TROSPIUM CL TAB 20MG 60 NDC CODE:68462046160 FDA MNBU0151926 001 PRODUCT CODE NO.:-61 K C A 6 9 H. T. S NO.: 3004.49.00.70 ANDA NO.:-91-575 THERAPEUTI CE USE:- TREATMENT OF VENOUS DISEASES URINARY INCONTINENC E THERAPY CARVEDILOL TAB 3 .125MG 500 NDC CODE:684620162 05 FDA PRODUCT CODE NO ; 62 MNBU0151926 001 O C A 22 H. T. S NO.: 3004.9 0.92.20 ANDA NO.:- 78-251 TH ERAPEUTICE USE:-BETA- ADRENO ACEPTOR ANTAGONIST COMMERC IAL & CUSTOM INVOICE NO. F224 52004524 DT. 21.12.2023 F2245 2004525 DT. 21.12.2023 F22452 004531 DT. 21.12.2023 F224520 MNBU0151926 001 04533 DT. 21.12.2023 SBILL NO : 6216284 DT 21-DEC-2023 SBIL L NO: 6216585 DT 21-DEC-2023 SBILL NO: 6217510 DT 21-DEC-20 23 SBILL NO: 6216590 DT 21-DE C-2023 NET WT. 6537.458 KGS 02 DATA LOGGERS NOTIFY PARTY:2 GLENMARK PHARMACEUTIC MNBU0151926 001 ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

45 PALLETS 3126 CARTONS P HARMACEUTICALS AS UNDER CAR VEDILOL TAB 3.125MG 500 NDC C ODE:68462016205 FDA PRODUCT C ODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- MNBU0429920 001 BETA- ADRENOACEPTOR ANTAGONI ST OLMESARTAN MEDOX TAB 5MG 90 NDC CODE:68462043690 FDA PRODUCT CODE NO.:62CCA68 H. T. S NO.: 3004.90.9220 ANDA NO.: 203281 THERAPEUTICE USE : :#TREATMENT OF HYPERTENSIO N, ALONE OR WITH OTHER ANTIH MNBU0429920 001 YPERTENSIVE AGENTS, TO LOWER BLOOD PRESSURE OMEPRAZOLE D R CAP 20MG 1000 NDC CODE:6846 2039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3004. 90.9160 ANDA NO.: 91672 THER APEUTICE USE: - -TREATMENT OF TREAT GASTROESOPHAGEAL REFLU MNBU0429920 001 X DISEASE GABAPENTIN TAB 6 00MG 500 NDC CODE:68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 3004.90.9 2.30 ANDA NO.:-77-662 THERAP EUTICE USE:-ANTICONVULSANT A GENT OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA MNBU0429920 001 PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE : - -TREATMENT OF TREAT GAST ROESOPHAGEAL REFLUX DISEASE ADAPALENE-BPO GEL PUMP 0.1/2 .5% 45GM NDC CODE:68462030147 FDA PRODUCT CODE NO.: 62 S MNBU0429920 001 D O 02 H. T. S NO.: 3004.90. 92.45 ANDA NO.: 208108 THERA PEUTICE USE: - USED ON THE SK IN TO TREAT ACNE ACYCLOVIR OINT 5% 30GM NDC CODE:684620 74635 FDA PRODUCT CODE NO.: 62 V C J 18 H. T. S NO.: 300 4.49.00.50 ANDA NO.: 205510 MNBU0429920 001 THERAPEUTICE USE: - AN ANTIVI RAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VIRUSES. EX AMPLES OF THESE INFECTIONS IN CLUDE HERPES AND SHINGLES ACYCLOVIR OINT 5% 15GM NDC CO DE:68462074617 FDA PRODUCT CO MNBU0429920 001 DE NO.: 62 V C J 18 H. T. S NO.: 3004.49.00.50 ANDA NO.: 205510 THERAPEUTICE USE: - A N ANTIVIRAL MEDICINE USED TO TREAT OR PREVENT INFECTIONS CAUSED BY CERTAIN KINDS OF VI RUSES. EXAMPLES OF THESE INFE CTIONS INCLUDE HERPES AND SHI MNBU0429920 001 NGLES ADAPALENE GEL 0.1% 15 GM (PLD) NDC CODE:69842008805 NDC NO.:69842008805 FDA PRO DUCT CODE NO.: 62 S C J 02 H . T. S NO.: 3004.40.00.50 AN DA NO.: 091314 THERAPEUTICE U SE: - TREATMENT OF ACNE AD APALENE GEL 0.1% 15GM (PLD) N MNBU0429920 001 DC CODE:69842008805 NDC NO.:6 9842008805 FDA PRODUCT CODE N O.: 62 S C J 02 H. T. S NO.: 3004.40.00.50 ANDA NO.: 091 314 THERAPEUTICE USE: - TREA TMENT OF ACNE ADAPALENE GEL 0.1% 45GM (PLD) NDC CODE:698 42008816 NDC NO.:69842008816 MNBU0429920 001 FDA PRODUCT CODE NO.: 62 S C J 02 H. T. S NO.: 3004.40.0 0.50 ANDA NO.: 091314 THERAP EUTICE USE: - TREATMENT OF AC NE ADAPALENE GEL 0.1% 45GM (PLD) NDC CODE:69842008816 N DC NO.:69842008816 FDA PRODUC T CODE NO.: 62 S C J 02 H. T MNBU0429920 001 . S NO.: 3004.40.00.50 ANDA NO.: 091314 THERAPEUTICE USE: - TREATMENT OF ACNE COMME RCIAL & CUSTOM INVOICE NO. F2 2452004248 DT. 30.11.2023 F22 452004284 DT. 30.11.2023 F224 52004287 DT. 30.11.2023 F2245 2004296 DT. 30.11.2023 F22452 MNBU0429920 001 004288 DT. 30.11.2023 F224520 04270 DT. 30.11.2023 F2245200 4285 DT. 30.11.2023 F22452004 254 DT. 30.11.2023 F224520042 36 DT. 30.11.2023 F2245200426 3 DT. 30.11.2023 F22452004237 DT. 30.11.2023 F22452004265 DT. 30.11.2023 S/BILL NO: 574 MNBU0429920 001 1924 DT 01-DEC-2023 S/BILL NO : 5741867 DT 01-DEC-2023 S/BI LL NO: 5741862 DT 01-DEC-2023 S/BILL NO: 5741921 DT 01-DEC- 2023 S/BILL NO: 5741866 DT 01 -DEC-2023 S/BILL NO: 5742756 DT 01-DEC-2023 S/BILL NO: 574 1923 DT 01-DEC-2023 S/BILL NO MNBU0429920 001 : 5741900 DT 01-DEC-2023 S/BI LL NO: 5741902 DT 01-DEC-2023 S/BILL NO: 5741898 DT 01-DEC- 2023 S/BILL NO: 5741865 DT 01 -DEC-2023 NET WT. 8665.91 KG S 00 DATA LOGGERS HUMIDITY:6 5% SET TEMPERATURE : +18 DEGR EES TEMPERATURE RANGE : +15 D MNBU0429920 001 EGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA NOTIFY PARTY:3 GLENMARK SPECIALTY S.A. SWITZERLAND (G SSA) PLACE DU PORT 2 NEUCHAT EL - 2000 SWITZERLAND NOTIFY MNBU0429920 001 PARTY:4 P&L DEVELOPMENT, LLC 275 GRAND BLVD NEW YORK WE STBURY USA- 11590 LABELER CO DE : 68462:

27 PALLETS 2352 CARTONS PH ARMACEUTICALS AS UNDER PRAV ASTATIN SOD TAB 10MG 90 NDC C ODE:68462019590 FDA PRODUCT C ODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO. :-77-987 THERAPEUTICE USE:-H MNBU3958568 001 YPOLIPDAEMIC NAPROXEN SOD T AB 550MG 500 NDC CODE:6846201 7905 FDA PRODUCT CODE NO.:-6 2 G C A 50 H. T. S NO.: 3004 .90.92.40 ANDA NO.:-78-314 T HERAPEUTICE USE:-ANTI -INFLAM MATORY, ANALGESIC CARVEDILO L TAB 12.5MG 100 NDC CODE:684 MNBU3958568 001 62016401 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-2 51 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST G ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S MNBU3958568 001 NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT EZETIMI BE TAB 10MG 90 NDC CODE:68462 022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 30 04.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOW MNBU3958568 001 ERING AGENT SIROLIMUS TAB 0 .5MG 100 NDC CODE:68462068201 FDA PRODUCT CODE NO.: 64 T C A 12 H. T. S NO.: 3004.90. 92.15 ANDA NO.: 208691 THERA PEUTICE USE: TO PREVENT REJEC TION OF KIDNEY TRANSPLANTS. COMMERCIAL & CUSTOM INVOICE MNBU3958568 001 NO. F22487001526 DT. 30.11.20 23 F22487001529 DT. 30.11.202 3 F22487001530 DT. 30.11.2023 F22487001531 DT. 30.11.2023 F22487001532 DT. 30.11.2023 S/BILL NO: 4018509 DT:30.11.20 23 S/BILL NO: 4018507 DT:30.1 1.2023 S/BILL NO: 4018506 DT: MNBU3958568 001 30.11.2023 S/BILL NO: 4018505 DT:30.11.2023 S/BILL NO: 401 8504 DT:30.11.2023 NET WT. 28 73.407 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK P HARMACEUTICALS INC 750, CORPO RATE DRIVE, NEW JERSEY MAHWA MNBU3958568 001 H - 07430 USA

6 PALLETS 749 CARTONS PHAR MACEUTICALS AS UNDER CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA MNBU0521471 001 - ADRENOACEPTOR ANTAGONIST EZETIMIBE TAB 10MG 500 NDC CODE:68462022605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO .: #078560 THERAPEUTICE USE: LIPID LOWERING AGENT COMME RCIAL & CUSTOM INVOICE NO. F2 MNBU0521471 001 2487001485 DT. 23.11.2023 F22 487001486 DT. 23.11.2023 S/BI LL NO: 4017908 DT: 23.11.2023 S/BILL NO: 4017907 DT: 23.11. 2023 NET WT. 1175.340 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE MNBU0521471 001 S TO +25 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

34 PALLETS 2008 CARTONS P HARMACEUTICALS AS UNDER EZE TIMIBE TAB 10MG 30 NDC CODE:6 8462022630 FDA PRODUCT CODE N O.: 61 J C A 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: #07 8560 THERAPEUTICE USE: LIPID TLLU1163267 001 LOWERING AGENT EZETIMIBE-S IMVA TAB 10/40MG 30 NDC CODE: 68462032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO. : 3004.49.00.10 ANDA NO.: 20 8699 THERAPEUTICE USE: - THIS COMBINATION MEDICATION IS U SED TO HELP LOWER BAD CHOLEST TLLU1163267 001 EROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN THE BLO OD. EZETIMIBE WORKS BY REDUCI NG THE AMOUNT OF CHOLESTEROL YOUR BODY ABSORBS FROM YOUR DIET. SIMVASTATIN BELONGS TO A GROUP OF DRUGS KNOWN AS "ST TLLU1163267 001 ATINS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MA DE BY THE LIVER. METFORMIN HCL ER TAB (Z) 1000MG 90 NDC CODE:68462052190 FDA PRODUCT CODE NO.: 61 P C A 55 H. T. S NO.: 3004.90.92.40 ANDA NO .:212969 THERAPEUTICE USE: TH TLLU1163267 001 E MANAGEMENT OF TYPE 2 DIABE TES DILTIAZEM HCL ER CAP 12 HR 60MG 100 NDC CODE:68462085 001 62 O C B 24 3004.49.00.1 0 212317 FOR THE TREATMENT O F HYPERTENSION. CARVEDIL OL TAB 12.5MG 500 NDC CODE:68 462016405 FDA PRODUCT CODE NO TLLU1163267 001 : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST EZETIMIBE TAB 10MG 90 NDC COD E:68462022690 FDA PRODUCT COD E NO.: 61 J C A 15 H. T. S N O.: 3004.49.00.10 ANDA NO.: TLLU1163267 001 #078560 THERAPEUTICE USE: LIP ID LOWERING AGENT TACROLIM US OINT 0.1% 60GM NDC CODE:68 462053465 FDA PRODUCT CODE NO .: 64 T C J 08 H. T. S NO.: 3004.49.00.50 ANDA NO.: 2103 93 THERAPEUTICE USE: - TACRO LIMUS IS A TOPICAL IMMUNOSUPP TLLU1163267 001 RESSIVE OINTMENT USED FOR THE TREATMENT OF MODERATE-TO-SE VERE ATOPIC DERMATITIS (ECZE MA). SIROLIMUS TAB 2MG 100 NDC CODE:68462068401 FDA PRO DUCT CODE NO.: 64 T C A 12 H . T. S NO.: 3004.90.92.15 AN DA NO.: 208691 THERAPEUTICE U TLLU1163267 001 SE: TO PREVENT REJECTION OF KIDNEY TRANSPLANTS. POTASSI UM CL ER CAP 10MEQ 100 NDC CO DE:68462035701 FDA PRODUCT CO DE NO.:65 R C F 14 H. T. S N O.: 3004.90.92.90 ANDA NO.:2 02868 THERAPEUTICE USE: - TR EATMENT OR PREVENTION OF HYPO TLLU1163267 001 KALEMIA POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:684620357 01 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90 .92.90 ANDA NO.:202868 THERA PEUTICE USE: - TREATMENT OR P REVENTION OF HYPOKALEMIA COMMERCIAL & CUSTOM INVOICE NO TLLU1163267 001 . F22487001464 DT. 21.11.2023 F22487001466 DT. 21.11.2023 F22487001467 DT. 21.11.2023 F22487001469 DT. 21.11.2023 F 22487001472 DT. 22.11.2023 S/ BILL NO: 4017836 DT: 22/11/202 3 S/BILL NO: 4017835 DT: 22/1 1/2023 S/BILL NO: 4017834 DT: TLLU1163267 001 22/11/2023 S/BILL NO: 401783 3 DT: 22/11/2023 S/BILL NO: 4 017832 DT: 22/11/2023 NET WT. 2903.005 KGS 02 DATA LOGGER S HUMIDITY:65% SET TEMPERATU RE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES NOTIFY PARTY:2 GLENMARK TLLU1163267 001 PHARMACEUTICALS INC 750, COR PORATE DRIVE, NEW JERSEY MAH WAH - 07430 USA

43 PALLETS 3447 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 6.25MG 500 NDC COD E:68462016305 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE MNBU0430577 001 TA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 6.25MG 100 NDC CODE:68462016301 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST CARVEDILOL TAB 6.2 MNBU0430577 001 5MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 1000 NDC CODE:68 462039710 FDA PRODUCT CODE N MNBU0430577 001 O.:62KCF10 H. T. S NO.: 3004 .90.9160 ANDA NO.:91672 THER APEUTICE USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEASE OMEPRAZOLE DR CAP 40MG 30 NDC CODE:68462039730 FDA PRODUCT CODE NO.: 62KCF 10 H. T. S NO.: 3004.90.9160 MNBU0430577 001 ANDA NO.: 91672 THERAPEUTIC E USE: - TREATMENT OF TREAT GASTROESOPHAGEAL REFLUX DISEA SE OMEPRAZOLE DR CAP 20MG 1 000 NDC CODE:68462039610 FDA PRODUCT CODE NO.: 62KCF10 H . T. S NO.: 3004.90.9160 AND A NO.: 91672 THERAPEUTICE USE MNBU0430577 001 : - TREATMENT OF TREAT GASTR OESOPHAGEAL REFLUX DISEASE CARVEDILOL TAB 6.25MG 500 ND C CODE:68462016305 FDA PRODUC T CODE NO : 62 O C A 22 H. T . S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE US E:-BETA- ADRENOACEPTOR ANTAG MNBU0430577 001 ONIST COMMERCIAL & CUSTOM I NVOICE NO. F22452003738 DT. 3 1.10.2023 F22452003757 DT. 31 .10.2023 F22452003777 DT. 31. 10.2023 F22452003796 DT. 31.1 0.2023 S/BILL NO: 5090096 DT 02-NOV-2023 S/BILL NO: 509009 0 DT 02-NOV-2023 S/BILL NO: 5 MNBU0430577 001 090087 DT 02-NOV-2023 S/BILL NO: 5090088 DT 02-NOV-2023 NE T WT. 7,864.194 KGS 01 DA TA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEM PERATURE RANGE : +15 DEGREES T O +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC MNBU0430577 001 750, CORPORATE DRIVE, NEW JE RSEY MAHWAH - 07430 USA

31 PALLETS 2831 CARTONS PH ARMACEUTICALS AS UNDER LITH IUM CARB ER TAB 300MG 100 NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00.20 ANDA N O.:91-544 THERAPEUTICE USE: - MNBU0415079 001 INDICATED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II T ERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR MNBU0415079 001 INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORDER. MAINTE NANCE THERAPY REDUCES THE FRE QUENCY OF MANIC EPISODES AND DIMINISHES THE INTENSITY OF THOSE EPISODES WHICH MAY OCC UR." LITHIUM CARB ER TAB 30 0MG 100 NDC CODE:68462022301 MNBU0415079 001 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.0 0.20 ANDA NO.:91-544 "THERAP EUTICE USE: - INDICATED IN TH E TREATMENT OF MANIC EPISODE S" OF BIPOLAR DISORDER. BIPO LAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRES MNBU0415079 001 SIVE ILLNESS, MANIC, IN THE O LDER DSM-II TERMINOLOGY. ALSO INDICATED AS A MAINTENANCE TREATMENT FOR INDIVIDUALS WI TH A DIAGNOSIS OF BIPOLAR DIS ORDER. MAINTENANCE THERAPY R EDUCES THE FREQUENCY OF MANIC EPISODES AND DIMINISHES THE MNBU0415079 001 INTENSITY OF THOSE EPISODES WHICH MAY OCCUR." CARVEDIL OL TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST MNBU0415079 001 LITHIUM CARB CAP 600MG 100 ND C CODE:68462022201 FDA PRODUC T CODE NO.:-61 N C E 37 H. T . S NO.: 3004.49.00.20 ANDA NO.:- 79 -139 THERAPEUTICE U SE:-ANTIMANIC AGENT CARVEDI LOL TAB 6.25MG 100 NDC CODE:6 8462016301 FDA PRODUCT CODE N MNBU0415079 001 O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST OMEPRAZOLE DR CAP 40MG 90 ND C CODE:68462039790 FDA PRODUC T CODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: MNBU0415079 001 91672 THERAPEUTICE USE: - -T REATMENT OF TREAT GASTROESOPH AGEAL REFLUX DISEASE ROPIN IROLE TAB 2MG 100 NDC CODE:68 462025601 FDA PRODUCT CODE N O.:-62 J C A 17 H. T. S NO.: 3004.90.92.40 ANDA NO.:- 90- 135 THERAPEUTICE USE:-TREATM MNBU0415079 001 ENT OF PARKINSONISM COMMER CIAL & CUSTOM INVOICE NO. F22 452002972 DT. 23.09.2023 F224 52002950 DT. 22.09.2023 F2245 2002981 DT. 24.09.2023 F22452 002982 DT. 24.09.2023 F224520 03003 DT. 25.09.2023 S/BILL N O: 4226785 DT 27-SEP-2023 S/B MNBU0415079 001 ILL NO: 4226772 DT 27-SEP-2023 S/BILL NO: 4227329 DT 27-SEP -2023 S/BILL NO: 4226617 DT 2 7-SEP-2023 S/BILL NO: 4226625 DT 27-SEP-2023 NET WT. 6465. 463 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PH MNBU0415079 001 ARMACEUTICALS INC 750, CORPOR ATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

46 PALLETS 3658 CARTONS PH ARMACEUTICALS AS UNDER NORE THINDRONE ACE TAB 5MG 50 NDC CODE:68462030450 FDA PRODUCT CODE NO.65 J C A 25 H. T. S NO.: 3004.39.00.50 ANDA NO.: -91-090 THERAPEUTICE USE:- S MNBU0422632 001 ECONDARY AMENORRHEA,ENDOMETRI OS IS AND ABNORMAL UTERINE B LEEDING LEVONORGESTREL/EE T AB 0.09/0.02MG 84 NDC CODE:68 462063729 FDA PRODUCT CODE NO .: 64 G D A 29 H. T. S NO.: 3006.60.0000 ANDA NO.: 20279 1 THERAPEUTICE USE: - : USED MNBU0422632 001 FOR PREVENTING PREGNANCY CARVEDILOL TAB 3.125MG 100 ND C CODE:68462016201 FDA PRODUC T CODE NO - 62 O C A 22 H. T . S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE US E:-BETA- ADRENOACEPTOR ANTAG ONIST CARVEDILOL TAB 3.125M MNBU0422632 001 G 500 NDC CODE:68462016205 F DA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92. 20 ANDA NO.:- 78-251 THERAPE UTICE USE:-BETA- ADRENOACEPT OR ANTAGONIST ONDANSETRON TAB 4MG 30 NDC CODE:684620105 30 FDA PRODUCT CODE NO.:-61 MNBU0422632 001 T C A 28 H. T. S NO.: 3004.9 0.92.40 ANDA NO.:- 77-535 TH ERAPEUTICE USE:-ANTI -EMETIC ZONISAMIDE CAP 100MG 100 N DC CODE:68462013001 FDA PRODU CT CODE NO.:-61 M C E 44 H. T. S NO.: 3004.49.00.20 ANDA NO.:-77-651 THERAPEUTICE US MNBU0422632 001 E:-ANTISEIZURE DRUG OXCARBA ZEPINE TAB 150MG 100 NDC CODE :68462013701 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT OXCARBAZE PINE TAB 600MG 100 NDC CODE:6 MNBU0422632 001 8462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77- 802 THERAPEUTICE USE:-ANTI C ONVULSANT AGENT OXCARBAZEPI NE TAB 150MG 100 NDC CODE:684 62013701 FDA PRODUCT CODE NO .:-61 M C A 45 H. T. S NO.: MNBU0422632 001 3004.90.92.30 ANDA NO.:-77-80 2 THERAPEUTICE USE:-ANTI CON VULSANT AGENT THEOPHYLLINE ER TAB 300MG 100 NDC CODE:684 62072101 63 B C B 30 3004.90 .92.85 212184 TO RELEASE TAB LETS ARE INDICATED FOR THE T REATMENT OF THE SYMPTOMS AND MNBU0422632 001 REVERSIBLE AIRFLOW OBSTRUCTI ON ASSOCIATED WITH CHRONIC AS THMA AND OTHER CHRONIC LUNG DISEASES, E.G., EMPHYSEMA AND CHRONIC BRONCHITIS CARVED ILOL TAB 3.125MG 500 NDC CODE :68462016205 FDA PRODUCT CODE NO ; 62 O C A 22 H. T. S NO MNBU0422632 001 .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22452002702 DT. 05.09.2 023 F22452002696 DT. 05.09.20 23 F22452002697 DT. 05.09.202 3 F22452002705 DT. 05.09.2023 MNBU0422632 001 F22452002706 DT. 05.09.2023 F22452002707 DT. 05.09.2023 F22452002708 DT. 05.09.2023 S /BILL NO: 3747588 DT 06-SEP-20 23 S/BILL NO: 3747589 DT 06-S EP-2023 S/BILL NO: 3747294 DT 06-SEP-2023 S/BILL NO: 37436 51 DT 06-SEP-2023 S/BILL NO: MNBU0422632 001 3747292 DT 06-SEP-2023 S/BILL NO: 3747298 DT 06-SEP-2023 S /BILL NO: 3747297 DT 06-SEP-20 23 NET WT. 7,162.785 KGS 02 DATA LOGGERS HUMIDITY:65% S ET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGREE S TO +25 DEGREES NOTIFY PARTY MNBU0422632 001 :2 GLENMARK PHARMACEUTICALS I NC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

10 PALLETS 787 CARTONS PHA RMACEUTICALS AS UNDER PIMEC ROLIMUS CREAM 1% 30GM NDC COD E:68462060935 FDA PRODUCT COD E NO.: 61 S C J 04 H. T. S N O.: 3004.90.92.45 ANDA NO.: 211769 THERAPEUTICE USE: - AS MNBU0471766 001 SECOUND-LINE THERAPY FOR TH E SHORT-TERM AND NON-CONTINUO S CHRONIC TRERTMENT OF MILD T O MODERATE ATOPIC DERMATITIS IN NON- IMMUNOCOMPROMISED ADULT AND CHILDREN 2 YEARS OF AGE CARVEDILOL TAB 25MG 50 0 NDC CODE:68462016505 FDA P MNBU0471766 001 RODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTIC E USE:-BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 2 5MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 MNBU0471766 001 2.20 ANDA NO.:- 78-251 THERA PEUTICE USE:-BETA- ADRENOACE PTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F224870 00989 DT. 31.08.2023 F2248700 0998 DT. 31.08.2023 F22487001 003 DT. 31.08.2023 S/BILL NO: 4013546 DT: 05/09/2023 S/BIL MNBU0471766 001 L NO:4013548 DT: 05/09/2023 S /BILL NO: 4013547 DT: 05/09/20 23 NET WT. 2560.957 KGS 04 D ATA LOGGERS SET TEMPERATURE : +18 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW J ERSEY MAHWAH - 07430 USA

31 PALLETS 2634 CARTONS PHARMACEUTICALS AS UNDER PR OPAFENONE HCL ER CAP 225MG 60 NDC CODE:68462040860 FDA PRO DUCT CODE NO.: 63 E C F 28 H . T. S NO.: 3004.49.00.10 AN DA NO.:205268 THERAPEUTICE US MNBU0520665 001 E:AN ANTIARRHYTHMIC AGENT. I T IS USED TO TREAT IRREGULAR HEART RHYTHM AND CAN SLOW RA PID HEARTBEATS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T MNBU0520665 001 HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: MNBU0520665 001 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST VORICONAZOLE TAB 200MG 30 N DC CODE:68462057330 FDA PRODU CT CODE NO.:61 W C A 59 H. T MNBU0520665 001 . S NO.: 3004.90.92.10 ANDA NO.:203503 THERAPEUTICE USE: -USED TO TREAT FUNGAL INFECT IONS PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FD A PRODUCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 211769 THERAPEUT MNBU0520665 001 ICE USE: - AS SECOUND-LINE TH ERAPY FOR THE SHORT-TERM AND NON-CONTINUOS CHRONIC TRERTM ENT OF MILD TO MODERATE ATOPI C DERMATITIS IN NON- IMMUNO COMPROMISED ADULT AND CHILDRE N 2 YEARS OF AGE EZETIMIBE TAB 10MG 500 NDC CODE:684620 MNBU0520665 001 22605 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 300 4.49.00.10 ANDA NO.: #078560 THERAPEUTICE USE: LIPID LOWE RING AGENT 02 DATA LOGGERS SET TEMPERATURE : +18 DEGRE ES NET WT:5648.991KGS COM MERCIAL & CUSTOM INVOICE NO. MNBU0520665 001 F22487000953 DT. 29.08.2023 F 22487000955 DT. 30.08.2023 F2 2487000956 DT. 30.08.2023 F22 487000958 DT. 30.08.2023 S/BI LL NO:4013197 DT:30.08.2023 S /BILL NO:4013196 DT:30.08.2023 S/BILL NO:4013193 DT:30.08.2 023 S/BILL NO:4013199 DT:30.0 MNBU0520665 001 8.2023 NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

33 PALLETS 2431 CARTONS PH ARMACEUTICALS AS UNDER RANO LAZINE ER TAB 1000MG 60 NDC C ODE:68462032060 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0603097 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA NAPROXEN MNBU0603097 001 SOD TAB 550MG 100 NDC CODE:68 462017901 FDA PRODUCT CODE N O.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-3 14 THERAPEUTICE USE:-ANTI -I NFLAMMATORY, ANALGESIC FENO FIBRATE CAP 134MG 100 NDC COD E:68462058101 FDA PRODUCT COD MNBU0603097 001 E NO.: 61 JCE 09 H. T. S NO. : 3004.90.92.20 ANDA NO.: 20 5566 THERAPEUTICE USE: - IND ICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, TOTAL-C, TRIGLYCERIDES AND APO B IN DULT PATIENTS WITH PRMARY HYPERCHOLESTEROL MNBU0603097 001 EMIA OR MIXED DYSLIPIDEMIA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST TACROLIMUS CAP 5MG 100 MNBU0603097 001 NDC CODE:68462068701 HTS NO: 3004.90.92.15 FDA CODE : 64 T C E 08 ANDA NO.206662 THER APEUTICE USE: TO PREVENT REJE CTION OF A KIDNEY, HEART, OR LIVER TRANSPLANT PIMECROLI MUS CREAM 1% 100GM NDC CODE:6 8462060994 FDA PRODUCT CODE N MNBU0603097 001 O.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 ANDA NO.: 211 769 THERAPEUTICE USE: - AS S ECOUND-LINE THERAPY FOR THE S HORT-TERM AND NON-CONTINUOS C HRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DERMATITIS IN NONIMMUNOCOMPROMISED ADULT MNBU0603097 001 AND CHILDREN 2 YEARS OF AGE PIMECROLIMUS CREAM 1% 30GM NDC CODE:68462060935 FDA PROD UCT CODE NO.: 61 S C J 04 H. T. S NO.: 3004.90.92.45 AND A NO.: 211769 THERAPEUTICE US E: - AS SECOUND-LINE THERAPY FOR THE SHORT-TERM AND NON-C MNBU0603097 001 ONTINUOS CHRONIC TRERTMENT OF MILD TO MODERATE ATOPIC DER MATITIS IN NON- IMMUNOCOMPR OMISED ADULT AND CHILDREN 2 YEARS OF AGE POTASSIUM CL E R CAP 10MEQ 500 NDC CODE:6846 2035705 FDA PRODUCT CODE NO.: 65 R C F 14 H. T. S NO.: 3 MNBU0603097 001 004.90.92.90 ANDA NO.: 202868 THERAPEUTICE USE: - TREATME NT OR PREVENTION OF HYPOKALEM IA CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE MNBU0603097 001 USE:-BETA- ADRENOACEPTOR AN TAGONIST COMMERCIAL & CUSTO M INVOICE NO. F22487000922 DT . 22.08.2023 F22487000924 DT. 22.08.2023 F22487000925 DT. 23.08.2023 F22487000928 DT. 2 3.08.2023 F22487000929 DT. 23 .08.2023 S/BILL NO: 4012795 D MNBU0603097 001 T: 23.08.2023 S/BILL NO: 4012 793 DT: 23.08.2023 S/BILL NO: 4012792 DT: 23.08.2023 S/BIL L NO: 4012797 DT: 23.08.2023 S/BILL NO: 4012798 DT: 23.08.2 023 NET WT. 6847.701 KGS 0 2 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES MNBU0603097 001 TEMPERATURE RANGE : +15 DEGRE ES TO +25 DEGREES NOTIFY PART Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA

22 PALLETS 839 CARTONS PHA RMACEUTICALS AS UNDER CLIND AMYCIN HCL CAP 300MG 100 NDC CODE:68462014401 FDA PRODUCT CODE NO.:56 J C E 20 H. T. S NO.: 2941.90.5000 ANDA NO.: 216957 THERAPEUTICE USE: :#A MNBU0329812 001 NTI-INFECTIVE AGENT PRAVAST ATIN SOD TAB 20MG 500 NDC COD E:68462019605 FDA PRODUCT COD E NO.:-61 J C A 13 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 77-987 THERAPEUTICE USE:-HYP OLIPDAEMIC INDOMETHACIN ER CAP 75MG 60 NDC CODE:68462032 MNBU0329812 001 560 FDA PRODUCT CODE: 62 GCE 42 H. T. S NO.:3004.90.92.40 ANDA NO.203501 THERAPEUTIC USE: INDOMETHACIN IS USED TO RELIEVE PAIN, SWELLING, AND JOINT STIFFNESS CAUSED BY ART HRITIS, GOUT, BURSITIS, AND T ENDONITIS. IT IS ALSO USED TO MNBU0329812 001 RELIEVE PAIN FROM VARIOUS OT HER CONDITIONS. THIS MEDICAT ION IS KNOWN AS A NONSTEROIDA L ANTI-INFLAMMATORY DRUG (NS AID). ... THIS EFFECT HELPS T O DECREASE SWELLING AND PAIN . CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PROD MNBU0329812 001 UCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 AND A NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST COMMERCIAL & CUSTOM INVOICE NO. F22487000832 DT. 31.07.2023 S/BILL NO: 40118 18 DT: 05.08.2023 NET WT. 3 MNBU0329812 001 271.454 KGS 23 DATA LOGGERS SET TEMPERATURE : +18 DEGREE S NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA

29 PALLETS 1954 CARTONS PHA RMACEUTICALS AS UNDER NAPROXE N TAB 500MG 500 NDC CODE:6846 2019005 FDA PRODUCT CODE NO. :-62 G C A 49 H. T. S NO.: 3 004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI-INFL MNBU0332550 001 AMMATORY, ANALGESIC CARVEDIL OL TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST GA BAPENTIN TAB 600MG 500 NDC CO MNBU0332550 001 DE:68462012605 FDA PRODUCT CO DE NO: 61 N C A 69 H. T. S N O.: 3004.90.92.30 ANDA NO.:- 77-662 THERAPEUTICE USE:-ANT ICONVULSANT AGENT PRAMIPEXOL E TAB 0.25MG 90 NDC CODE:6846 2033190 FDA PRODUCT CODE NO.: 62 J C A 15 H. T. S NO.: 3 MNBU0332550 001 004.90.92.40 ANDA NO.: 90-781 THERAPEUTICE USE: USED IN P ARKINSONS DISEASE RIZATRIPTAN BENZ ODT TAB 5MG 18UD NDC CO DE:68462046706 FDA PRODUCT CO DE NO.: 60 L C A 87 H. T. S NO.: 3004.90.92.28 ANDA NO.: 201914 THERAPEUTICE USE: - A MNBU0332550 001 NALGESIC/ HUMAN - RX/SINGLE I NGREDIENT / PROMPT RELEASE T ABLETS / RIZATRIPTAN BENZOATE (ANALGESIC) 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM I MNBU0332550 001 NVOICE NO. F22452002054 DT. 2 9.07.2023 F22452002062 DT. 29 .07.2023 F22452002075 DT. 30. 07.2023 S/BILLNO:2865863 DT 3 1-JUL-2023 S/BILL NO:2863672 DT 31-JUL-2023 S/BILL NO:2865 600 DT 31-JUL-2023 NOTIFY PAR TY:2 GLENMARK PHARMACEUTICALS MNBU0332550 001 INC 750, CORPORATE DRIVE, N EW JERSEY MAHWAH - 07430 USA

40 PALLETS 3391 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 12.5MG 100 NDC COD E:68462016401 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE MNBU0565485 001 TA- ADRENOACEPTOR ANTAGONIST CLINDAMYCIN HCL CAP 300MG 100 NDC CODE:68462014401 P RAVASTATIN SOD TAB 10MG 500 N DC CODE:68462019505 FDA PRODU CT CODE NO.:-61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE US MNBU0565485 001 E:-HYPOLIPDAEMIC DILTIAZEM HCL ER CAP 12HR 120MG 100 NDC CODE:68462056201 62 O C B 24 3004.49.00.10 212317 FOR T HE TREATMENT OF HYPERTENSION. FENOFIBRATE CAP 134MG 100 NDC CODE:68462058101 FDA PRO DUCT CODE NO.: 61 JCE 09 H. MNBU0565485 001 T. S NO.: 3004.90.92.20 ANDA NO.: 205566 THERAPEUTICE USE : - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUC TION OF LDL-C, TOTAL-C, TRIGL YCERIDES AND APO B IN DULT P ATIENTS WITH PRMARY HYPERCHO LESTEROLEMIA OR MIXED DYSLIPI MNBU0565485 001 DEMIA CARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FD A PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.2 0 ANDA NO.:- 78-251 THERAPEU TICE USE:-BETA- ADRENOACEPTO R ANTAGONIST 02 DATA LOG GERS SET TEMPERATURE : +18 MNBU0565485 001 DEGREES COMMERCIAL & CU STOM INVOICE NO. F22487000799 DT. 30.07.2023 F22487000800 DT. 30.07.2023 S/BILL NO:4011 527 DT:31.07.2023 S/BILL NO:4 011528 DT:31.07.2023 NET WT:6 971.280 KGS NOTIFY PARTY:2 S HOROUQ COMMODITIES TRADING DMC MNBU0565485 001 C UNIT NO. 98, DMCC BUSINESS CENTRE, LEVEL NO. 8, JEWELLER Y & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR.

23 PALLETS 1668 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 6.25MG 500 NDC COD E:68462016305 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S N O.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE MNBU0600204 001 TA- ADRENOACEPTOR ANTAGONIST NAPROXEN TAB 500MG 500 ND C CODE:68462019005 FDA PRODUC T CODE NO.:-62 G C A 49 H. T . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C CARVEDILOL TAB 6.25MG 500 MNBU0600204 001 NDC CODE:68462016305 FDA PR ODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 A NDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST NAPROXEN TAB 500M G 500 NDC CODE:68462019005 F DA PRODUCT CODE NO.:-62 G C A MNBU0600204 001 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEU TICE USE:-ANTI-INFLAMMATORY, ANALGESIC COMMERCIAL & CUS TOM INVOICE NO. F22452002033 DT. 28.07.2023 F22452002034 D T. 28.07.2023 S/BILL NO: 2820 274 DT. 29-JUL-2023 S/BILL NO MNBU0600204 001 : 2820272 DT. 29-JUL-2023 0 2 DATA LOGGERS SET TEMPERAT URE : +18 DEGREES NOTIFY PA RTY:2 GLENMARK PHARMACEUTICAL S INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 US A

42 PALLETS 3465 CARTONS PH ARMACEUTICALS AS UNDER HEAT HER TAB 0.35MG 84 NDC CODE:68 462030329 FDA PRODUCT CODE NO .: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO.:90-45 4 THERAPEUTICE USE: PREVENTI MNBU0263947 001 ON OF PREGNANCY. CARVEDILOL TAB 12.5MG 500 NDC CODE:6846 2016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST CO LESEVELAM HCL OS 3.75GM 30 ND MNBU0263947 001 C CODE:68462062030 FDA PRODUC T CODE NO.: 62 B C L 13 H. T . S NO.: 3004.49.00.10 ANDA NO.: 202190 THERAPEUTICE USE : - COLESEVELAM IS A LIPID ( LOW DENSITY LIPOPROTIN CHOLES TEROL) REDUCING DRUG THAT IS USEFUL FOR REDUCING CHOLESTER MNBU0263947 001 OL. CARVEDILOL TAB 3.125MG 500 NDC CODE:68462016205 FDA PRODUCT CODE NO ; 62 O C A 2 2 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUT ICE USE:-BETA- ADRENOACEPTOR ANTAGONIST OLMESARTAN MED OX TAB 5MG 30 NDC CODE:684620 MNBU0263947 001 43630 FDA PRODUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.90 .9220 ANDA NO.: 203281 THERA PEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS , TO LOWER BLOOD PRESSURE S/BILL NO: 2764780 DT 27-JUL- MNBU0263947 001 2023 S/BILL NO: 2764769 DT 27 -JUL-2023 S/BILL NO: 2764785 DT 27-JUL-2023 S/BILL NO: 276 4789 DT 27-JUL-2023 COMME RCIAL & CUSTOM INVOICE NO. F2 2452001992 DT. 26.07.2023 F22 452001994 DT. 26.07.2023 F224 52001995 DT. 26.07.2023 F2245 MNBU0263947 001 2001996 DT. 26.07.2023 NET WT . 6032.34 KGS 02 DATA LOGGER S SET TEMPERATURE : +18 DEG REES NOTIFY PARTY:2 SHOROU Q COMMODITIES TRADING DMCC UN IT NO. 98, DMCC BUSINESS CENTR E, LEVEL NO. 8, JEWELLERY & G EMPLEX 2, DUBAI DUBAI UTD.A MNBU0263947 001 RAB EMIR.

PHARMACEUTICALS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 6.25MG 100 NDC CODE 68462016301 FDA PRODUCT CODE NO 62 O C A 22 H. T. S NO. HLBU9283689 001 3004.90.92.20 ANDA NO. - 78-251 THERAPEUTICE USE -BETA- ADRENOACEPTOR ANTAGONIST CARVEDILOL TAB 6.25MG 500 NDC CODE 68462016305 HLBU9283689 001 FDA PRODUCT CODE NO 62 O C A 22 H. T. S NO. 3004.90.92.20 ANDA NO. - 78-251 THERAPEUTICE USE -BETA- ADRENOACEPTOR HLBU9283689 001 ANTAGONIST MUPIROCIN OINT 2% 22GM NDC CODE 68462018022 FDA PRODUCT CODE NO. 61 G J J 81 H. T. S NO. 3004.90.92.45 ANDA NO. 90-480 HLBU9283689 001 THERAPEUTICE USE - ANTI-BACTERIAL IMIQUIMOD CREAM 5% 0.25GM 24 NDC CODE 68462053670 FDA PRODUCT CODE NO. 62 V C J 29 H. T. S NO. 3004.49.00.50 HLBU9283689 001 ANDA NO. 201994 THERAPEUTICE USE - INDICATED FOR ACTINIC KERATOSES AND EXTERNAL GENITAL AND PERIANAL WARTS MUPIROCIN OINT 2% 22GM NDC CODE 68462018022 HLBU9283689 001 FDA PRODUCT CODE NO. 61 G J J 81 H. T. S NO. 3004.90.92.45 ANDA NO. 90-480 THERAPEUTICE USE - ANTI-BACTERIAL NORGEST/EE TAB 0.25/0.035MG 84 HLBU9283689 001 NDC CODE 68462030929 FDA PRODUCT CODE NO. 65 J D A 27 H. T. S NO. 3006.60.00.00 ANDA NO. 200538 THERAPEUTICE USE - ORAL CONTRACEPTIVES HLBU9283689 001 HAILEY 24 FE TAB 1MG/20MCG-75MG 84 NDC CODE 68462073129 FDA PRODUCT CODE NO. 65 J D A 25 H. T. S NO. 3006.60.00.00 ANDA NO. 204847 HLBU9283689 001 THERAPEUTICE USE - CONTRACEPTION TO PREVENT PREGNANCY 02 DATA LOGGERS HUMIDITY 65% TEMPERATURE RANGE +15 DEGREES TO +25 DEGREES COMMERCIAL & HLBU9283689 001 CUSTOM INVOICE NO. F22452001645 DT. 30.06.2023 F22452001664 DT. 30.06.2023 F22452001638 DT. 30.06.2023 F22452001654 DT. 30.06.2023 F22452001659 DT. 30.06.2023 F22452001657 DT. 30.06.2023 HBL NO BOM0057051 HLBU9283689 001 SCAC CODE YASV

29 PALLETS 1692 CARTONS PHA RMACEUTICALS AS UNDER TELMI SARTAN-HCTZ TAB 80MG/12.5MG 30 UD NDC CODE:68462084113 62 O D A 09 3004.90.92.20 202544 TELMISARTAN AND HYDROCHLORO THIAZIDE TABLETS ARE INDICATE MNBU0400823 001 D FOR THE TREATMENT OF HYPE RTENSION, TO LOWER BLOOD PRES SURE. CARVEDILOL TAB 25MG 5 00 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTI CE USE:-BETA- ADRENOACEPTOR MNBU0400823 001 ANTAGONIST EZETIMIBE TAB 1 0MG 90 NDC CODE:68462022690 FDA PRODUCT CODE NO.: 61 J C A 15 H. T. S NO.: 3004.49.00 .10 ANDA NO.: #078560 THERAP EUTICE USE: LIPID LOWERING AG ENT TELMISARTAN-HCTZ TAB 80 MG/25MG 30UD NDC CODE:6846208 MNBU0400823 001 4213 62 O D A 09 3004.90.92. 20 202544 TELMISARTAN AND H YDROCHLOROTHIAZIDE TABLETS AR E INDICATED FOR THE TREATMEN T OF HYPERTENSION, TO LOWER BLOOD PRESSURE. CARVEDILOL TAB 25MG 500 NDC CODE:6846201 6505 FDA PRODUCT CODE NO : 6 MNBU0400823 001 2 O C A 22 H. T. S NO.: 3004 .90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE NOACEPTOR ANTAGONIST 02 DA TA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2248700 0624 DT. 30.06.2023 F22487000 MNBU0400823 001 630 DT. 30.06.2023 F224870006 41 DT. 30.06.2023 S/BILL:NO:4 009948 DT:04.07.2023 S/BILL: NO:4009946 DT:04.07.2023 S/BI LL NO:4009949 DT:04.07.2023 NOTIFY PARTY:2 SHOROUQ COMMO DITIES TRADING DMCC UNIT NO. 98, DMCC BUSINESS CENTRE, LEV MNBU0400823 001 EL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMI R.

PHARMACEUTICALS AS UNDER CARVEDILOL TAB 25 MG 500 NDC CODE:68462016505 FDA PRODUCT COD E NO : 62 O C A 22 H. T. S NO.: 3004.90.92 .20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGONIST 00 DATA LOGGERS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE RANGE : +15 DE HLBU9080790 001 GREES TO +25 DEGREES

PHARMACEUTICALS AS UNDER CARVEDILOL TAB 12 .5MG 500 NDC CODE:68462016405 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONIST 0 1 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREES TEMPERATURE RANGE : +15 DEGRE HLBU9635521 001 ES TO +25 DEGREES

25 PALLETS 1784 CARTONS PHA RMACEUTICALS AS UNDER CARVEDI LOL TAB 12.5MG 500 NDC CODE:6 8462016405 FDA PRODUCT CODE N O : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78 -251 THERAPEUTICE USE:-BETA- MNBU0489425 001 ADRENOACEPTOR ANTAGONIST N APROXEN TAB 500MG 500 NDC COD E:68462019005 FDA PRODUCT COD E NO.:-62 G C A 49 H. T. S N O.: 3004.90.92.40 ANDA NO.:- 78-250 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC CA RVEDILOL TAB 12.5MG 500 NDC C MNBU0489425 001 ODE:68462016405 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST NAPROXEN TAB 500MG 100 ND C CODE:68462019001 FDA PRODUC T CODE NO.:-62 G C A 49 H. T MNBU0489425 001 . S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE :-ANTI-INFLAMMATORY, ANALGESI C NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-250 THERAPEUTICE USE: MNBU0489425 001 -ANTI-INFLAMMATORY, ANALGESIC 01 DATA LOGGERS HUMIDITY:65 % SET TEMPERATURE : +18 DEGRE ES TEMPERATURE RANGE : +15 DE GREES TO +25 DEGREES COMMERCI AL & CUSTOM INVOICE NO. F2245 2001364 DT. 18.06.2023 F22452 001374 DT. 19.06.2023 NET WT: MNBU0489425 001 6,284.078 NOTIFY PARTY:2 GLE NMARK PHARMACEUTICALS INC 750 , CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

31 PALLETS 2380 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B MNBU0584633 001 ETA- ADRENOACEPTOR ANTAGONIS T OXCARBAZEPINE TAB 600MG 1 00 NDC CODE:68462013901 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO.:-77-802 THERAPEUTIC E USE:-ANTI CONVULSANT AGENT CARVEDILOL TAB 3.125MG 500 MNBU0584633 001 NDC CODE:68462016205 FDA PRO DUCT CODE NO ; 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST LITHIUM CARB CAP 6 00MG 100 NDC CODE:68462022201 FDA PRODUCT CODE NO.:-61 N MNBU0584633 001 C E 37 H. T. S NO.: 3004.49. 00.20 ANDA NO.:- 79 -139 THE RAPEUTICE USE:-ANTIMANIC AGEN T MUPIROCIN OINT 2% 22GM N DC CODE:68462018022 FDA PRODU CT CODE NO.: 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-480 THERAPEUTICE USE MNBU0584633 001 : - ANTI-BACTERIAL COMMERC IAL & CUSTOM INVOICE NO. F224 52001238 DT. 09.06.2023 F2245 2001239 DT. 09.06.2023 F22452 001244 DT. 10.06.2023 F224520 01233 DT. 09.06.2023 S/BILL N O: 1666674 DT 10-JUN-2023 S/B ILL NO: 1666574 DT 10-JUN-2023 MNBU0584633 001 S/BILL NO: 1671611 DT 10-JUN -2023 S/BILL NO: 1666738 DT 1 0-JUN-2023 NET WT. 6,441.13 K GS 02 DATA LOGGERS SET TEM PERATURE : +18 DEGREES NOTI FY PARTY:2 GLENMARK PHARMACEU TICALS INC 750, CORPORATE DRI VE, NEW JERSEY MAHWAH - 0743 MNBU0584633 001 0 USA

21 PALLETS 1437 CARTONS PH ARMACEUTICALS AS UNDER OXCA RBAZEPINE TAB 600MG 100 NDC C ODE:68462013901 FDA PRODUCT C ODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92.30 ANDA NO. :-77-802 THERAPEUTICE USE:-AN MNBU0647243 001 TI CONVULSANT AGENT CARVED ILOL TAB 6.25MG 100 NDC CODE: 68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST HEATHER TAB 0.35MG 84 NDC C MNBU0647243 001 ODE:68462030329 FDA PRODUCT C ODE NO.: 65 J C A 24 H. T. S NO.: 3006.60.00.00 ANDA NO. :90-454 THERAPEUTICE USE: PR EVENTION OF PREGNANCY. COMM ERCIAL & CUSTOM INVOICE NO. F 22452001220 DT. 08.06.2023 F2 2452001222 DT. 08.06.2023 F22 MNBU0647243 001 452001232 DT. 09.06.2023 S/BI LL NO: 1659760 DT 10-JUN-2023 S/BILL NO: 1659763 DT 10-JUN- 2023 S/BILL NO: 1659762 DT 10 -JUN-2023 NET WT. 3,317.91 KG S 02 DATA LOGGERS SET TEMP ERATURE : +18 DEGREES NOTIF Y PARTY:2 GLENMARK PHARMACEUT MNBU0647243 001 ICALS INC 750, CORPORATE DRIV E, NEW JERSEY MAHWAH - 07430 USA

11 PALLETS 765 CARTONS PHA RMACEUTICALS AS UNDER EZETI MIBE-SIMVA TAB 10/40MG 30 NDC CODE:68462032330 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA N O.: 208699 THERAPEUTICE USE: MNBU4164140 001 - THIS COMBINATION MEDICATION IS USED TO HELP LOWER BAD C HOLESTEROL AND FATS (SUCH AS LDL, TRIGLYCERIDES) AND RAISE GOOD CHOLESTEROL (HDL) IN T HE BLOOD. EZETIMIBE WORKS BY REDUCING THE AMOUNT OF CHOLES TEROL YOUR BODY ABSORBS FROM MNBU4164140 001 YOUR DIET. SIMVASTATIN BELON GS TO A GROUP OF DRUGS KNOWN AS "STATINS." IT WORKS BY RED UCING THE AMOUNT OF CHOLESTER OL MADE BY THE LIVER. TOPI RAMATE ER CAP (Q) 200MG 30 ND C CODE:68462037130 3004.49.00 .20 61 M C B 40 210278 TO MNBU4164140 001 PIRAMATE ER CAP (Q) 50MG 30 N DC CODE:68462037330 3004.49.0 0.20 61 M C B 40 210278 N APROXEN SOD TAB 550MG 100 NDC CODE:68462017901 FDA PRODUCT CODE NO.:-62 G C A 50 H. T. S NO.: 3004.90.92.40 ANDA N O.:-78-314 THERAPEUTICE USE:- MNBU4164140 001 ANTI -INFLAMMATORY, ANALGESIC AMLOD-OLMESARTAN TAB 5/40M G 30 NDC CODE:68462056830 FD A PRODUCT CODE NO.: 62 C D A 68 H. T. S NO.: 3004.90.92.2 0 ANDA NO.: 207807 THERAPEUT ICE USE: -MEDICATION USED TO TREAT HIGH BLOOD PRESSURE AND MNBU4164140 001 CORONARY ARTERY DISEASE C ARVEDILOL TAB 12.5MG 500 NDC CODE:68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: -BETA- ADRENOACEPTOR ANTAGON IST S/BILL NO: 4007870 DT: MNBU4164140 001 30.05.2023 COMMERCIAL & CUSTO M INVOICE NO. F22487000390 DT . 29.05.2023 NET WT.1199.553 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES NOTIFY PA RTY:2 SHOROUQ COMMODITIES TRA MNBU4164140 001 DING DMCC UNIT NO. 98, DMCC B USINESS CENTRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD.ARAB EMIR.

PHARMACEUTICALS AS UNDER TELMISARTAN TAB 4 0MG 30 NDC CODE:68462020030 FDA PRODUCT COD E NO.: 62 O C A 09 H. T. S NO.: 3004.90.92 .20 ANDA NO.:090032 THERAPEUTICE USE: INDI CATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE OMEPRAZOLE DR CAP 2 0MG 1000 NDC CODE:68462039610 FDA PRODUCT C ONEU9141599 001 ODE NO.: 62KCF10 H. T. S NO.: 3004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREA TMENT OF TREAT GASTROESOPHAGEAL REFLUX DISE ASE CARVEDILOL TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78- 251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST GABAPENTIN TAB 800MG 500 NDC ONEU9141599 001 CODE:68462012705 FDA PRODUCT CODE NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO .:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGENT 01 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22452000627 DT. 09.05.20 23 F22452000628 DT. 09.05.2023 F22452000629 ONEU9141599 001 DT. 09.05.2023

PHARMACEUTICALS AS UNDER TELMISARTAN TAB 4 0MG 30 NDC CODE:68462020030 FDA PRODUCT COD E NO.: 62 O C A 09 H. T. S NO.: 3004.90.92 .20 ANDA NO.:090032 THERAPEUTICE USE: INDI CATED FOR THE TREATMENT OF HYPERTENSION, TO LOWER BLOOD PRESSURE CARVEDILOL TAB 6.25 MG 500 NDC CODE:68462016305 FDA PRODUCT COD TTNU8772159 001 E NO : 62 O C A 22 H. T. S NO.: 3004.90.92 .20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BE TA- ADRENOACEPTOR ANTAGONIST FLUCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CO DE : 68462011944 HTS NO : 3004.90.92.45 FD A CODE : 61 W C A 45 ANDA NO. : 77 - 253 TH ERAPEUTICE USE : ANTIFUNGAL OLMESARTAN ME DOX TAB 5MG 30 NDC CODE:68462043630 FDA PRO TTNU8772159 001 DUCT CODE NO.: 62CCA68 H. T. S NO.: 3004.9 0.9220 ANDA NO.: 203281 THERAPEUTICE USE: - -TREATMENT OF HYPERTENSION, ALONE OR WITH OTHER ANTIHYPERTENSIVE AGENTS, TO LOWER BL OOD PRESSURE CARVEDILOL TAB 3.125MG 100 N DC CODE:68462016201 FDA PRODUCT CODE NO - 6 2 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRE TTNU8772159 001 NOACEPTOR ANTAGONIST 01 DATA LOGGERS H UMIDITY:65% SET TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F224520006 49 DT. 09.05.2023 F22452000650 DT. 10.05.202 3 F22452000651 DT. 10.05.2023 F22452000652 DT. 10.05.2023 F22452000653 DT. 10.05.2023

24 PALLETS 1779 CARTONS P HARMACEUTICALS AS UNDER NAP ROXEN TAB 500MG 500 NDC CODE: 68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO. : 3004.90.92.40 ANDA NO.:-78 -250 THERAPEUTICE USE:-ANTI- MNBU0549360 001 INFLAMMATORY, ANALGESIC CA RVEDILOL TAB 6.25MG 500 NDC C ODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST FLUCONAZOLE TAB 200MG 30 MNBU0549360 001 NDC CODE:68462010430 FDA PR ODUCT CODE NO : 61 W C A 45 H. T. S NO.: 3004.90.92.45 A NDA NO.:-77 - 253 THERAPEUTIC E USE:-ANTIFUNGAL OMEPRAZO LE DR CAP 20MG 1000 NDC CODE: 68462039610 FDA PRODUCT CODE NO.: 62KCF10 H. T. S NO.: 3 MNBU0549360 001 004.90.9160 ANDA NO.: 91672 THERAPEUTICE USE: - -TREATMEN T OF TREAT GASTROESOPHAGEAL R EFLUX DISEASE TOPIRAMATE T AB 25MG 60 NDC CODE:684620108 60 FDA PRODUCT CODE NO.:-61 M C A 40 H. T. S NO.: 3004.4 9.00.20 ANDA NO.:- 77-627 TH MNBU0549360 001 ERAPEUTICE USE:-ANTICONVULSAN T 01 DATA LOGGERS SET T EMPERATURE : +18 DEGREES NET WT:4561.78 KGS INV NO :F22452000594 DT. 06.05.2023 INV NO:F22452000595 DT. 06.05. 2023 INV NO:F22452000597 DT. 06.05.2023 S/BILL NO:9855046 MNBU0549360 001 DT:08.05.2023 S/BILL NO:98550 33 DT:08.05.2023 S/BILL NO:98 55036 DT:08.05.2023 NOTIFY PARTY:2 SHOROUQ COMMODITIE S TRADING DMCC UNIT NO. 98 , DMCC BUSINESS CENTRE, LE VEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UT MNBU0549360 001 D.ARAB EMIR.

8 PALLETS 1312 CARTONS PH ARMACEUTICALS AS UNDER CARV EDILOL TAB 3.125MG 500 NDC CO DE:68462016205 FDA PRODUCT CO DE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.: - 78-251 THERAPEUTICE USE:-B MNBU0564920 001 ETA- ADRENOACEPTOR ANTAGONIS T CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PR ODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 A NDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR A NTAGONIST 00 DATA LOGGERS MNBU0564920 001 HUMIDITY:65% SET TEMPERATUR E : +18 DEGREES TEMPERATURE RANGE : +15 DEGREES TO +25 DEG REES INV NO:F22452000582 D T. 05.05.2023 S/BILL NO:98202 26 DT:06.05.2023 NOTIFY PAR TY:2 GLENMARK PHARMACEUTIC ALS INC 750, CORPORATE DRI MNBU0564920 001 VE, NEW JERSEY MAHWAH - 07430 USA

41 PALLETS 2175 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC MNBU0147079 001 ONVULSANT AGENT CARVEDILOL TAB 12.5MG 100 NDC CODE:6846 2016401 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3 004.90.92.20 ANDA NO.:- 78-25 1 THERAPEUTICE USE:-BETA- A DRENOACEPTOR ANTAGONIST PR AVASTATIN SOD TAB 20MG 500 ND MNBU0147079 001 C CODE:68462019605 FDA PRODUC T CODE NO.:-61 J C A 13 H. T . S NO.: 3004.90.92.20 ANDA NO.:-77-987 THERAPEUTICE USE :-HYPOLIPDAEMIC CARVEDILOL TAB 12.5MG 500 NDC CODE:68462 016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 MNBU0147079 001 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- AD RENOACEPTOR ANTAGONIST CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET MNBU0147079 001 A- ADRENOACEPTOR ANTAGONIST TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PRO DUCT CODE NO.: 64 T C J 08 H . T. S NO.: 3004.49.00.50 AN DA NO.: 210393 THERAPEUTICE U SE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSIVE OINTMENT MNBU0147079 001 USED FOR THE TREATMENT OF MO DERATE-TO-SEVERE ATOPIC DERMA TITIS (ECZEMA). POTASSIUM CL ER CAP 10MEQ 100 NDC CODE: 68462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:2028 68 THERAPEUTICE USE: - TREAT MNBU0147079 001 MENT OR PREVENTION OF HYPOKA LEMIA COMMERCIAL & CUSTOM I NVOICE NO. F22487000157 DT. 2 9.04.2023 F22487000158 DT. 29 .04.2023 F22487000168 DT. 30. 04.2023 F22487000183 DT. 30.0 4.2023 F22487000190 DT. 30.04 .2023 S/BILL NO:4006413 DT: 0 MNBU0147079 001 4.05.2023 S/BILL NO:4006414 D T: 04.05.2023 S/BILL NO:40064 16 DT: 04.05.2023 S/BILL NO: 4006417 DT: 04.05.2023 S/BILL NO:4006418 DT: 04.05.2023 NE T WT.8495.324 02 DATA LOGGE RS HUMIDITY:65% SET TEMPERAT URE : +18 DEGREES TEMPERATURE MNBU0147079 001 RANGE : +15 DEGREES TO +25 DE GREES NOTIFY PARTY:2 GLENMAR K PHARMACEUTICALS INC 750, CO RPORATE DRIVE, NEW JERSEY MA HWAH - 07430 USA

38 PALLETS 1951 CARTONS PH ARMACEUTICALS AS UNDER GABA PENTIN TAB 600MG 500 NDC CODE :68462012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO. : 3004.90.92.30 ANDA NO.:-77 -662 THERAPEUTICE USE:-ANTIC MNBU0535670 001 ONVULSANT AGENT TACROLIMUS CAP 5MG 100 NDC CODE:6846206 8701 HTS NO: 3004.90.92.15 F DA CODE : 64 T C E 08 ANDA NO .206662 THERAPEUTICE USE: TO PREVENT REJECTION OF A KIDNE Y, HEART, OR LIVER TRANSPLANT TACROLIMUS OINT 0.1% 100GM MNBU0535670 001 NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERM MNBU0535670 001 ATITIS (ECZEMA). PROPAFENO NE HCL ER CAP 225MG 60 NDC CO DE:68462040860 FDA PRODUCT CO DE NO.: 63 E C F 28 H. T. S NO.: 3004.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE:AN A NTIARRHYTHMIC AGENT. IT IS US ED TO TREAT IRREGULAR HEART R MNBU0535670 001 HYTHM AND CAN SLOW RAPID HE ARTBEATS PROPAFENONE HCL ER CAP 325MG 60 NDC CODE:684620 40960 FDA PRODUCT CODE NO.: 63 E C F 28 H. T. S NO.: 300 4.49.00.10 ANDA NO.: 205268 THERAPEUTICE USE: -AN ANTIARR HYTHMIC AGENT IT IS USED TO T MNBU0535670 001 REAT IRREGULAR HEARTRHYTHM AN D CAN SLOW RAPID HEARTBEATS TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PROD UCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 AND A NO.: 210393 THERAPEUTICE US E: - TACROLIMUS IS A TOPICAL MNBU0535670 001 IMMUNOSUPPRESSIVE OINTMENT U SED FOR THE TREATMENT OF MOD ERATE-TO-SEVERE ATOPIC DERMAT ITIS (ECZEMA). DILTIAZEM H CL ER CAP 12HR 60MG 100 NDC C ODE:68462085001 62 O C B 24 3004.49.00.10 212317 FOR THE TREATMENT OF HYPERTENSION. MNBU0535670 001 CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA N O.:- 78-251 THERAPEUTICE USE :-BETA- ADRENOACEPTOR ANTAGO NIST POTASSIUM CL ER CAP 10 MEQ 100 NDC CODE:68462035701 MNBU0535670 001 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92 .90 ANDA NO.:202868 THERAPEU TICE USE: - TREATMENT OR PREV ENTION OF HYPOKALEMIA CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO MNBU0535670 001 .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET A- ADRENOACEPTOR ANTAGONIST COMMERCIAL & CUSTOM INVOICE NO. F22487000167 DT. 30.04.2 023 F22487000172 DT. 30.04.20 23 F22487000178 DT. 30.04.202 3 F22487000179 DT. 30.04.2023 MNBU0535670 001 F22487000180 DT. 30.04.2023 F22487000181 DT. 30.04.2023 F22487000186 DT. 30.04.2023 S/BILL NO: 4006447 DT: 04.05. 2023 S/BILL NO: 4006448 DT: 0 4.05.2023 S/BILL NO: 4006449 DT: 04.05.2023 S/BILL NO: 400 6450 DT: 04.05.2023 S/BILL NO MNBU0535670 001 : 4006451 DT: 04.05.2023 S/BI LL NO: 4006453 DT: 04.05.2023 S/BILL NO: 4006452 DT: 04.05. 2023 NET WT.6487.98 00 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +18 DEGREES T EMPERATURE RANGE : +15 DEGREES TO +25 DEGREES NOTIFY PARTY: MNBU0535670 001 2 GLENMARK PHARMACEUTICALS IN C 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

27 PALLETS 1796 CARTONS P HARMACEUTICALS AS UNDER RAN OLAZINE ER TAB 500MG 60 NDC C ODE:68462031960 FDA PRODUCT C ODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO. :211082 THERAPEUTIC USE: - IT MNBU0516618 001 IS AN ANTI-ANGINAL MEDICATI ON. IT WORKS BY IMPROVING BLO OD FLOW TO HELP THE HEART WOR K MORE EFFICIENTLY. IT IS USE D TO TREAT CHRONIC ANGINA (C HEST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA RANOLAZIN MNBU0516618 001 E ER TAB 1000MG 60 NDC CODE:6 8462032060 FDA PRODUCT CODE N O.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.:2110 82 THERAPEUTIC USE: - IT IS AN ANTI-ANGINAL MEDICATION. I T WORKS BY IMPROVING BLOOD FL OW TO HELP THE HEART WORK MOR MNBU0516618 001 E EFFICIENTLY. IT IS USED TO TREAT CHRONIC ANGINA (CHEST PAIN). IT IS NOT FOR USE DURI NG AN ACUTE (EMERGENCY) ATTAC K OF ANGINA EZETIMIBE-SIMV A TAB 10/40MG 30 NDC CODE:684 62032330 FDA PRODUCT CODE NO. : 61 J D C 15 H. T. S NO.: MNBU0516618 001 3004.49.00.10 ANDA NO.: 20869 9 THERAPEUTICE USE: - THIS C OMBINATION MEDICATION IS USED TO HELP LOWER BAD CHOLESTERO L AND FATS (SUCH AS LDL, TRI GLYCERIDES) AND RAISE GOOD CH OLESTEROL (HDL) IN THE BLOOD. EZETIMIBE WORKS BY REDUCING MNBU0516618 001 THE AMOUNT OF CHOLESTEROL YO UR BODY ABSORBS FROM YOUR DIE T. SIMVASTATIN BELONGS TO A G ROUP OF DRUGS KNOWN AS "STATI NS." IT WORKS BY REDUCING THE AMOUNT OF CHOLESTEROL MADE BY THE LIVER. TOPIRAMATE ER CAP (Q) 25MG 30 NDC CODE:684 MNBU0516618 001 62037230 3004.49.00.20 61 M C B 40 210278 RUFINAMIDE T AB 400MG 120 NDC CODE:6846207 1408 61 M C A 99 3004.90.92. 30 205075 TO USED WITH OTHER MEDICATIONS TO PREVENT OR C ONTROL SEIZURES (EPILEPSY) A SSOCIATED WITH LENNOX-GASTAUT MNBU0516618 001 SYNDROME (LGS FENOFIBRATE CAP 200MG 100 NDC CODE:68462 058201 FDA PRODUCT CODE NO.: 61 JCE 09 H. T. S NO.: 3004 .90.92.20 ANDA NO.: 205566 T HERAPEUTICE USE: - INDICATED AS ADJUNCTIVE THERAPY TO DIET FOR THE REDUCTION OF LDL-C, MNBU0516618 001 TOTAL-C, TRIGLYCERIDES AND A PO B IN DULT PATIENTS WITH P RMARY HYPERCHOLESTEROLEMIA OR MIXED DYSLIPIDEMIA CARVED ILOL TAB 12.5MG 500 NDC CODE: 68462016405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO. : 3004.90.92.20 ANDA NO.:- 7 MNBU0516618 001 8-251 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONIST EZETIMIBE-SIMVA TAB 10/40MG 90 NDC CODE:68462032390 FDA PRODUCT CODE NO.: 61 J D C 15 H. T. S NO.: 3004.49.00.10 ANDA NO.: 208699 THERAPEUTIC E USE: :#LIPID LOWERING AGENT MNBU0516618 001 TACROLIMUS OINT 0.1% 100GM NDC CODE:68462053494 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3004.49.00.50 A NDA NO.: 210393 THERAPEUTICE USE: - TACROLIMUS IS A TOPICA L IMMUNOSUPPRESSIVE OINTMENT USED FOR THE TREATMENT OF M MNBU0516618 001 ODERATE-TO-SEVERE ATOPIC DERM ATITIS (ECZEMA). 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATURE : +18 DEGREE S TEMPERATURE RANGE : +15 DEGREES TO +25 DEGREES COM MERCIAL & CUSTOM INVOICE NO. F22487000139 DT. 26.04.2023 F MNBU0516618 001 22487000141 DT. 26.04.2023 F2 2487000142 DT. 26.04.2023 S /BILL NO:4005995 DT:27.04.2023 S/BILL NO:4005998 DT:27.04.2 023 S/BILL NO:4006001 DT:27.0 4.2023 NET WT.:2452.388 NO TIFY PARTY:2 GLEN MARK PHARMACEUTICALS INC MNBU0516618 001 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

50 PALLETS 2943 CARTONS PHAR MACEUTICALS AS UNDER MUPIRO CIN OINT 2% 22GM NDC CODE:684 62018022 FDA PRODUCT CODE NO. : 61 G J J 81 H. T. S NO.: 3004.90.92.45 ANDA NO.: 90-48 0 THERAPEUTICE USE: - ANTI-B MNBU0257672 001 ACTERIAL NAPROXEN TAB 500MG 5 00 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92.40 ANDA NO.:-78-250 THERAPEUTIC E USE:-ANTI-INFLAMMATORY, AN ALGESIC OXCARBAZEPINE TAB 300 MG 100 NDC CODE:68462013801 MNBU0257672 001 FDA PRODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.90.92 .30 ANDA NO.:-77-802 THERAPE UTICE USE:-ANTI CONVULSANT AG ENT LAMOTRIGINE TAB CD 25MG 1 00 NDC CODE:68462022901 FDA PRODUCT CODE NO.:- 61 M C A 3 8 H. T. S NO.: 3004.90.92.30 MNBU0257672 001 ANDA NO.:-79 # 099 THERAPEU TICE USE:- ANTICONVULSANT NA PROXEN TAB 500MG 500 NDC CODE :68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO .: 3004.90.92.40 ANDA NO.:-7 8-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC CAR MNBU0257672 001 VEDILOL TAB 3.125MG 500 NDC C ODE:68462016205 FDA PRODUCT C ODE NO ; 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO. :- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONI ST OXCARBAZEPINE TAB 300MG 10 0 NDC CODE:68462013801 FDA P MNBU0257672 001 RODUCT CODE NO.:-61 M C A 45 H. T. S NO.: 3004.9092.30 A NDA NO.:-77-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT N ET WT::11771.69 KGS 02 DATA LOGGERS SET TEMPERATURE : +18 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F2245200 MNBU0257672 001 0409 DT. 27.04.2023 F22452000 405 DT. 27.04.2023 F224520004 06 DT. 27.04.2023 F2245200039 7 DT. 26.04.2023 F22452000384 DT. 26.04.2023 F22452000385 DT. 26.04.2023 F22452000386 D T. 26.04.2023 S/BILL NO:963 4815 DT:28.04.2023 S/BILL NO: MNBU0257672 001 9634808 DT:28.04.2023 S/BILL NO:9634814 DT:28.04.2023 S/BI LL NO:9636651 DT:28.04.2023 S /BILL NO:9634817 DT:28.04.2023 S/BILL NO:9634804 DT:28.04.2 023 S/BILL NO:9634813 DT:28.0 4.2023 NOTIFY PARTY:2 SHOR OUQ COMMODITIES TRADING DMCC MNBU0257672 001 UNIT NO. 98, DMCC BUSINESS CEN TRE, LEVEL NO. 8, JEWELLERY & GEMPLEX 2, DUBAI DUBAI UTD .ARAB EMIR.

PHARMACEUTICALS AS UNDER NAPROXEN TAB 375M G 500 NDC CODE:68462018905 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 3004.90.92. 40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI -INFLAMMATORY, ANALGESIC NAPROXEN TAB 500 MG 500 NDC CODE:68462019005 FDA PRODUCT COD E NO.:-62 G C A 49 H. T. S NO.: 3004.90.92 TEMU9330652 001 .40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANT I-INFLAMMATORY, ANALGESIC CARVEDILOL TAB 25MG 500 NDC CODE:68462016505 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONIST CARVEDILO L TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 TEMU9330652 001 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST 01 DATA LOGGERS HUMIDITY:65% SET TEMPERATU RE : +20 DEGREES TEMPERATURE RANGE : +15 DEG REES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F22452000065 DT. 09.04.2023 F22 452000074 DT. 10.04.2023

12 PALLETS 985 CARTONS P HARMACEUTICALS AS UNDER CAR VEDILOL TAB 25MG 500 NDC CODE :68462016505 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO .: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BET MNBU0656271 001 A- ADRENOACEPTOR ANTAGONIST PRAVASTATIN SOD TAB 40MG 90 NDC CODE:68462019790 FDA PR ODUCT CODE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 A NDA NO.: 77-987 THERAPEUTICE USE: -HYPOLIPDAEMIC PRAVAS TATIN SOD TAB 40MG 500 NDC CO MNBU0656271 001 DE:68462019705 FDA PRODUCT CO DE NO.: 61 J C A 13 H. T. S NO.: 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTICE USE: -H YPOLIPDAEMIC CARVEDILOL TAB 6.25MG 500 NDC CODE:68462016 305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004. MNBU0656271 001 90.92.20 ANDA NO.:- 78-251 T HERAPEUTICE USE:-BETA- ADREN OACEPTOR ANTAGONIST COMMER CIAL & CUSTOM INVOICE NO. F22 452000095 DT. 11.04.2023 S/BI LL NO: 9246990 DT 12-APR-2023 NET WT.2926.74 05 DATA LOGG ERS HUMIDITY:65% SET TEMPERA MNBU0656271 001 TURE : +18 DEGREES TEMPERATUR E RANGE : +15 DEGREES TO +25 D EGREES NOTIFY PARTY:2 GLENMA RK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY M AHWAH - 07430 USA

PHARMACEUTICALS AS UNDER CLINDAMYCIN HCL C AP 150MG 100 NDC CODE:68462014301 CLINDAM YCIN HCL CAP 150MG 500 NDC CODE:68462014305 POTASSIUM CL ER CAP 10MEQ 100 NDC CODE:68 462035701 FDA PRODUCT CODE NO.:65 R C F 14 H. T. S NO.: 3004.90.92.90 ANDA NO.:202868 THERAPEUTICE USE: - TREATMENT OR PREVENTIO SZLU9440976 001 N OF HYPOKALEMIA CLINDAMYCIN HCL CAP 300 MG 100 NDC CODE:68462014401 TACROLIMUS OI NT 0.1% 30GM NDC CODE:68462053435 FDA PRODU CT CODE NO.: 64 T C J 08 H. T. S NO.: 3004 .49.00.50 ANDA NO.: 210393 THERAPEUTICE USE : - TACROLIMUS IS A TOPICAL IMMUNOSUPPRESSI VE OINTMENT USED FOR THE TREATMENT OF MODE RATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA). SZLU9440976 001 CARVEDILOL TAB 12.5MG 500 NDC CODE:684620 16405 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANT AGONIST RANOLAZINE ER TAB 500MG 60 NDC CO DE:68462031960 FDA PRODUCT CODE NO.: 61 D C B 02 H. T. S NO.: 3004.49.00.10 ANDA NO.: 211082 THERAPEUTIC USE: - IT IS AN ANTI-ANG SZLU9440976 001 INAL MEDICATION. IT WORKS BY IMPROVING BLOO D FLOW TO HELP THE HEART WORK MORE EFFICIEN TLY. IT IS USED TO TREAT CHRONIC ANGINA (CH EST PAIN). IT IS NOT FOR USE DURING AN ACUTE (EMERGENCY) ATTACK OF ANGINA TACROLIMUS OINT 0.1% 60GM NDC CODE:68462053465 FDA PR ODUCT CODE NO.: 64 T C J 08 H. T. S NO.: 3 004.49.00.50 ANDA NO.: 210393 THERAPEUTICE SZLU9440976 001 USE: - TACROLIMUS IS A TOPICAL IMMUNOSUPPRE SSIVE OINTMENT USED FOR THE TREATMENT OF M ODERATE-TO-SEVERE ATOPIC DERMATITIS (ECZEMA ). 02 DATA LOGGERS HUMIDITY:65% SE T TEMPERATURE : +20 DEGREES TEMPERATURE RANG E : +15 DEGREES TO +25 DEGREES CONTAINER NO. SZLU9440976 COMMERCIAL & CUSTOM INVOICE NO. F22387002459 DT. 31.03.2023 F2238700246 SZLU9440976 001 9 DT. 31.03.2023 F22387002472 DT. 31.03.2023 F22387002476 DT. 31.03.2023 F22387002490 D T. 31.03.2023 F22387002493 DT. 31.03.2023 F 22387002501 DT. 31.03.2023

PHARMACEUTICALS AS UNDER CARVEDILOL TAB 6. 25MG 500 NDC CODE:68462016305 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONIST CARVEDILO L TAB 25MG 500 NDC CODE:68462016505 FDA PRO DUCT CODE NO : 62 O C A 22 H. T. S NO.: 30 FBIU5108378 001 04.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST HUM IDITY:65% SET TEMPERATURE : +20 DEGREES TEM PERATURE RANGE : +15 DEGREES TO +25 DEGREES COMMERCIAL & CUSTOM INVOICE NO. F224520000 34 DT. 05.04.2023

30 PALLETS 2214 CARTONS PHARMACEUTICALS AS UNDER CICLOPIROX OLAMINE CR EAM 0.77% 30GM NDC CODE:6 8462029735 FDA PRODUCT CODE NO.:-61 W C J 03 H. T. S NO.: 3004.40.49.50 AND SUDU8191854 001 A NO.:- 90 - 273 THERAPEUTI CE USE:-ANTIFUNGAL USE. CICLOPIROX OLAMINE CREAM 0.77% 90GM NDC CODE:6846202 9792 FDA PRODUCT CODE NO .:-61 W C J 03 H. T. S NO.: 3004.40.49.50 ANDA NO.: - 90 - 273 THERAPEUTICE SUDU8191854 001 USE:-ANTIFUNGAL USE. P RAMIPEXOLE TAB 1.5MG 90 NDC CODE:68462033490 FDA PRODU CT CODE NO.: 62 J C A 15 H. T. S NO.: 3004.90.92.40 ANDA NO.: 90-781 THERAP EUTICE USE: USED IN PARKINS ONS DISEASE CARVEDILOL SUDU8191854 001 TAB 6.25MG 500 NDC CODE:68 462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR ANTAGONIST GABAPEN TIN TAB 800MG 500 NDC CODE: SUDU8191854 001 68462012705 FDA PRODUCT COD E NO : 61 N C A 69 H. T. S NO.: 3004.90.92.30 AN DA NO.:-77-662 THERAPEUTICE USE:-ANTICONVULSANT AGE NT COMMERCIAL & CUSTOM INVOICE NO. F22352005838 D T. 10.03.2023 F22352005840 SUDU8191854 001 DT. 10.03.2023 F22352005842 DT. 10.03.2023 F2235200584 4 DT. 10.03.2023 F223520058 45 DT. 10.03.2023 S/BILL NO : 8405161 DT 11-MAR-2023 S/ BILL NO: 8404617 DT 11-MAR-202 3 S/BILL NO: 8405167 DT 11- MAR-2023 S/BILL NO: 8404631 SUDU8191854 001 DT 11-MAR-2023 S/BILL NO: 8404622 DT 11-MAR-2023 NET WT.7604.59 KGS 01 DATA LOGG ERS SET TEMPERATURE : + 20 DEGREES NOTIFY PARTY :2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NEW JERSEY MAHWAH - 0743 SUDU8191854 001 0 USA

14 PALLETS 626 CARTONS PHARMACEUTICALS AS UNDER CARVEDILOL TAB 6.25MG 100 NDC CODE:68462016301 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 300 4.90.92.20 ANDA NO.:- 78-25 SUDU8191854 001 1 THERAPEUTICE USE:-BETA - ADRENOACEPTOR ANTAGONI ST NAPROXEN TAB 500MG 500 NDC CODE:68462019005 FDA PRODUCT CODE NO.:-62 G C A 49 H. T. S NO.: 300 4.90.92.40 ANDA NO.:-78-250 THERAPEUTICE USE:-ANTI- SUDU8191854 001 INFLAMMATORY, ANALGESIC COMMERCIAL & CUSTOM INVOI CE NO. F22352005843 DT. 10. 03.2023 S/BILL NO: 8404630 DT 11-MAR-2023 NET WT.3509. 11 01 DATA LOGGERS HUMID ITY:65% SET TEMPERATURE : + 20 DEGREES TEMPERATURE RANG SUDU8191854 001 E : +15 DEGREES TO +25 DEGREES NOTIFY PARTY:2 GLENMARK PHARMACEUTICALS INC 750, C ORPORATE DRIVE, NEW JERSEY MAHWAH - 07430 USA

43 PALLETS 2964 CARTONS PHARMACEUTICALS AS UNDER C ARVEDILOL TAB 6.25MG 500 NDC CODE:68462016305 FDA PRODUCT CODE NO : 62 O C A 22 H. T. S NO.: 3004.90.92.20 ANDA NO .:- 78-251 THERAPEUTICE USE: MNBU0578707 001 -BETA- ADRENOACEPTOR ANTAGON IST LITHIUM CARB ER TAB 300 MG 100 NDC CODE:68462022301 FDA PRODUCT CODE NO.: 61 N C B 37 H. T. S NO.: 3004.49.00 .20 ANDA NO.:91-544 THERAPEU TICE USE: - INDICATED IN THE TREATMENT OF MANIC EPISODES MNBU0578707 001 OF BIPOLAR DISORDER. BIPOLAR DISORDER, MANIC (DSM-IV) IS EQUIVALENT TO MANIC DEPRESSIV E ILLNESS, MANIC, IN THE OLDE R DSM-II TERMINOLOGY. ALSO I NDICATED AS A MAINTENANCE TR EATMENT FOR INDIVIDUALS WITH A DIAGNOSIS OF BIPOLAR DISORD MNBU0578707 001 ER. MAINTENANCE THERAPY REDU CES THE FREQUENCY OF MANIC EP ISODES AND DIMINISHES THE INT ENSITY OF THOSE EPISODES WHI CH MAY OCCUR. LITHIUM CARB ER TAB 450MG 100 NDC CODE:68 462022401 FDA PRODUCT CODE NO .: 61 N C B 37 H. T. S NO.: MNBU0578707 001 3004.49.00.20 ANDA NO.:91-61 6 THERAPEUTICE USE: - INDICA TED IN THE TREATMENT OF MANIC EPISODES OF BIPOLAR DISORDE R. BIPOLAR DISORDER, MANIC ( DSM-IV) IS EQUIVALENT TO MANI C DEPRESSIVE ILLNESS, MANIC, IN THE OLDER DSM-II TERMINOLO MNBU0578707 001 GY. ALSO INDICATED AS A MAIN TENANCE TREATMENT FOR INDIVID UALS WITH A DIAGNOSIS OF BIP OLAR DISORDER. MAINTENANCE TH ERAPY REDUCES THE FREQUENCY O F MANIC EPISODES AND DIMINIS HES THE INTENSITY OF THOSE E PISODES WHICH MAY OCCUR. G MNBU0578707 001 ABAPENTIN TAB 600MG 500 NDC C ODE:68462012605 FDA PRODUCT C ODE NO: 61 N C A 69 H. T. S NO.: 3004.90.92.30 ANDA NO.: -77-662 THERAPEUTICE USE:-AN TICONVULSANT AGENT OXCARBA ZEPINE TAB 300MG 100 NDC CODE :68462013801 FDA PRODUCT CODE MNBU0578707 001 NO.:-61 M C A 45 H. T. S NO .: 3004.90.92.30 ANDA NO.:-7 7-802 THERAPEUTICE USE:-ANTI CONVULSANT AGENT GABAPENTI N TAB 600MG 500 NDC CODE:6846 2012605 FDA PRODUCT CODE NO: 61 N C A 69 H. T. S NO.: 30 04.90.92.30 ANDA NO.:-77-662 MNBU0578707 001 THERAPEUTICE USE:-ANTICONVUL SANT AGENT MUPIROCIN CREAM 2% 30GM NDC CODE:68462056435 FDA PRODUCT CODE NO.: 61GCJ 82 H. T. S NO.: 3004.90.92.4 5 ANDA NO.: 201587 THERAPEUT ICE USE: - TOPICAL ANTI-BACTE RIAL COMMERCIAL & CUSTOM IN MNBU0578707 001 VOICE NO. F22352005609 DT. 26 .02.2023 F22352005610 DT. 26. 02.2023 F22352005611 DT. 26.0 2.2023 F22352005623 DT. 27.02 .2023 F22352005614 DT. 26.02. 2023 NET WT.11781.16 KGS 02 DATA LOGGERS SET TEMPERATUR E : +20 DEGREES NOTIFY PART MNBU0578707 001 Y:2 GLENMARK PHARMACEUTICALS INC 750, CORPORATE DRIVE, NE W JERSEY MAHWAH - 07430 USA S/BILL NO: 8143270 DT 28- FEB-2023 S/BILL NO: 8143268 D T 28-FEB-2023 S/BILL NO: 8143 228 DT 28-FEB-2023 S/BILL NO: 8143272 DT 28-FEB-2023 S/BIL MNBU0578707 001 L NO: 8143230 DT 28-FEB-2023

43 PALLETS 1724 CARTONS PHARMACEUTICALS AS UNDER FL UCONAZOLE TAB 150MG 12UD NDC CODE:68462011944 NDC CODE : 68462011944 HTS NO : 3004.90. 92.45 FDA CODE : 61 W C A 45 ANDA NO. : 77 - 253 THERAPEU MNBU0613808 001 TICE USE : ANTIFUNGAL TRAN DO-VERAPAMIL TAB 2/240MG 100 NDC CODE:68462029601 FDA PROD UCT CODE NO.:-62 O D A 11 H. T. S NO.: 3004.90.92.20 AND A NO.:-79-135 THERAPEUTICE U SE:-TREATMENT OF HYPERTENSION CARVEDILOL TAB 12.5MG 500 MNBU0613808 001 NDC CODE:68462016405 FDA PRO DUCT CODE NO : 62 O C A 22 H . T. S NO.: 3004.90.92.20 AN DA NO.:- 78-251 THERAPEUTICE USE:-BETA- ADRENOACEPTOR AN TAGONIST COMMERCIAL & CUSTO M INVOICE NO. F22352005482 DT . 20.02.2023 F22352005483 DT. MNBU0613808 001 20.02.2023 S/BILL NO: 7931 637 DT: 20-FEB-23 S/BILL NO: 7931636 DT: 20-FEB-23 NET W T.4676.58 KGS 02 DATA LOGGERS HUMIDITY:65% SET TEMPERATUR E : +20 DEGREES TEMPERATURE R ANGE : +15 DEGREES TO +25 DEGR EES NOTIFY PARTY:2 GLENMARK MNBU0613808 001 PHARMACEUTICALS INC 750, CORP ORATE DRIVE, NEW JERSEY MAHW AH - 07430 USA

PHARMACEUTICALS AS UNDER CARVEDILOL TAB 12 .5MG 100 NDC CODE:68462016401 FDA PRODUCT C ODE NO : 62 O C A 22 H. T. S NO.: 3004.90. 92.20 ANDA NO.:- 78-251 THERAPEUTICE USE:- BETA- ADRENOACEPTOR ANTAGONIST PRAVASTAT IN SOD TAB 40MG 90 NDC CODE:68462019790 FDA PRODUCT CODE NO.: 61 J C A 13 H. T. S NO.: OERU4081714 001 3004.90.92.20 ANDA NO.: 77-987 THERAPEUTI CE USE: -HYPOLIPDAEMIC CARVEDILOL TAB 12. 5MG 100 NDC CODE:68462016401 FDA PRODUCT CO DE NO : 62 O C A 22 H. T. S NO.: 3004.90.9 2.20 ANDA NO.:- 78-251 THERAPEUTICE USE:-B ETA- ADRENOACEPTOR ANTAGONIST 01 DATA LO GGERS HUMIDITY:65% SET TEMPERATURE : +20 DE GREES TEMPERATURE RANGE : +15 DEGREES TO +25 OERU4081714 001 DEGREES CONTAINER NO. OERU4081714 COMME RCIAL & CUSTOM INVOICE NO. F22352005303 DT. 09.02.2023 F22352005304 DT. 09.02.2023